kw1	kw2	pg	crit_p	edge_weight	inv_edge_weight	R1C1	iteration
nivolumab/adverse effects	carcinoma non-small-cell lung/drug therapy	0.004553302075907761	0.008155167897148229	0.240219629375429	0.8192464059779487	1	1
nivolumab/adverse effects	ipilimumab/adverse effects	0.0	0.0	2.5111394794997657e-06	0.008727969937297866	7	1
nivolumab/adverse effects	colitis/chemically induced	0.0035537959139343434	0.006525421840167472	0.36030611328699463	0.00017652040385932665	10	1
nivolumab/adverse effects	paclitaxel/therapeutic use	0.0026775126805036464	0.004970087232236068	0.1276595744680851	0.8192464059779487	1	1
nivolumab/adverse effects	oropharyngeal neoplasms/drug therapy	4.384131353618592e-06	2.0359121441010303e-05	0.1276595744680851	0.8192464059779487	1	1
nivolumab/adverse effects	disease susceptibility	4.384131353618592e-06	2.0359121441010303e-05	0.1276595744680851	0.8192464059779487	1	1
nivolumab/adverse effects	colitis ulcerative/chemically induced	0.0026775126805036464	0.004970087232236068	0.1276595744680851	0.8192464059779487	1	1
nivolumab/adverse effects	drug-related side effects and adverse reactions/diagnosis	0.00019844215462494486	0.00047626117109986763	0.1276595744680851	0.8192464059779487	1	1
nivolumab/adverse effects	postoperative complications	4.384131353618592e-06	2.0359121441010303e-05	0.1276595744680851	0.8192464059779487	1	1
nivolumab/adverse effects	hashimoto disease/chemically induced	0.0026775126805036464	0.004970087232236068	0.1276595744680851	0.8192464059779487	1	1
nivolumab/adverse effects	prednisolone/therapeutic use	4.384131353618592e-06	2.0359121441010303e-05	0.1276595744680851	0.8192464059779487	1	1
nivolumab/adverse effects	immune checkpoint inhibitors/adverse effects	0.0008925751342884203	0.001906652642877882	0.13951048248097603	0.0007106107119884933	9	1
nivolumab/adverse effects	lung neoplasms/drug therapy	0.0026775126805036464	0.004970087232236068	0.240219629375429	0.8192464059779487	1	1
nivolumab/adverse effects	protein kinase inhibitors/therapeutic use	0.0006000839098009303	0.0013378919956217462	0.1276595744680851	0.8192464059779487	1	1
nivolumab/adverse effects	squamous cell carcinoma of head and neck/drug therapy	0.0026775126805036464	0.004970087232236068	0.1276595744680851	0.8192464059779487	1	1
nivolumab/adverse effects	tongue neoplasms/drug therapy	0.0026775126805036464	0.004970087232236068	0.1276595744680851	0.8192464059779487	1	1
carcinoma non-small-cell lung/drug therapy	pneumonia/chemically induced	0.00013503101229361825	0.00036756769553535334	0.06314344543582703	0.8192464059779487	1	1
carcinoma non-small-cell lung/drug therapy	ipilimumab/therapeutic use	4.279068232793115e-05	0.0001479542236423382	0.06314344543582705	0.8192464059779487	1	1
neoplasms/drug therapy	glucocorticoids/therapeutic use	0.0035053074158596376	0.006442186602120416	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	virus diseases/etiology	0.0008429884284459899	0.0018343526874300567	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	escherichia coli infections/drug therapy	0.0008429884284459899	0.0018343526874300567	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	immune checkpoint inhibitors/adverse effects	2.919420854663457e-05	0.00010163171575961524	0.00710293900853693	4.0365872528276203e-05	11	1
neoplasms/drug therapy	tryptophan/pharmacology	6.822554857377483e-05	0.00019602833674718404	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	protein kinase inhibitors/therapeutic use	0.0008429884284459899	0.0018343526874300567	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	disease progression	0.0035053074158596376	0.006442186602120416	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	chemical and drug induced liver injury/diagnosis	2.1897680313465173e-07	1.5040830922380118e-06	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	diarrhea/chemically induced	0.000262296342385393	0.0006229156443145538	0.02146669245206154	0.06969840871389302	5	1
neoplasms/drug therapy	clostridium infections/chemically induced	0.0008429884284459899	0.0018343526874300567	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	colitis/chemically induced	0.0014435094939846405	0.002875741570047526	0.13102727028986286	4.0365872528276203e-05	11	1
neoplasms/drug therapy	abdominal pain/chemically induced	0.0035053074158596376	0.006442186602120416	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	anti-bacterial agents/adverse effects	0.0008429884284459899	0.0018343526874300567	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	intestinal mucosa/immunology	7.80791054233454e-06	3.2506403074209105e-05	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	feces/chemistry	0.0002938788735177278	0.0006828165170571351	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	colon/immunology	5.006444148136779e-10	4.2732828712129836e-09	0.015099519560741249	0.5658111483402343	2	1
neoplasms/drug therapy	leukocyte l1 antigen complex/analysis	0.0002938788735177278	0.0006828165170571351	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	t-lymphocyte subsets/immunology	7.80791054233454e-06	3.2506403074209105e-05	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	gastritis/complications	0.0035053074158596376	0.006442186602120416	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	biological products/therapeutic use	6.822554857377483e-05	0.00019602833674718404	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	hepatitis/diagnosis	2.1897680313465173e-07	1.5040830922380118e-06	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	butyrates/metabolism	2.1897680313465173e-07	1.5040830922380118e-06	0.1276595744680851	0.8192464059779487	1	1
neoplasms/drug therapy	AHR	6.822554857377483e-05	0.00019602833674718404	0.1276595744680851	0.8192464059779487	1	1
interleukin-17/genetics	APC	0.003954425372989068	0.007113781094266048	0.02127659574468085	0.8192464059779487	1	1
interleukin-17/genetics	IL17A	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
interleukin-17/genetics	MIR15B	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
interleukin-17/genetics	NRF1	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
interleukin-17/genetics	micrornas/genetics	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
interleukin-17/genetics	gene expression regulation neoplastic	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
interleukin-17/genetics	lymphocytes tumor-infiltrating/metabolism	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
interleukin-17/genetics	t-lymphocytes cytotoxic/immunology	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
interleukin-17/genetics	tumor microenvironment/drug effects	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
interleukin-17/genetics	ht29 cells	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
interleukin-17/genetics	colorectal neoplasms/drug therapy	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
interleukin-17/genetics	b7-h1 antigen/genetics	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
APC	myeloid-derived suppressor cells/metabolism	0.0020566383584686987	0.004003380010759681	0.02127659574468085	0.8192464059779487	1	1
APC	gene expression regulation neoplastic	0.003954425372989068	0.007113781094266048	0.02127659574468085	0.8192464059779487	1	1
APC	micrornas/genetics	0.003954425372989068	0.007113781094266048	0.02127659574468085	0.8192464059779487	1	1
APC	lymphocytes tumor-infiltrating/metabolism	0.003954425372989068	0.007113781094266048	0.02127659574468085	0.8192464059779487	1	1
APC	azoxymethane/adverse effects	0.0020566383584686987	0.004003380010759681	0.02127659574468085	0.8192464059779487	1	1
APC	ht29 cells	0.003954425372989068	0.007113781094266048	0.02127659574468085	0.8192464059779487	1	1
APC	t-lymphocytes cytotoxic/immunology	0.003954425372989068	0.007113781094266048	0.02127659574468085	0.8192464059779487	1	1
APC	immune checkpoint inhibitors/administration & dosage	0.0015629549934901288	0.0031076298116178	0.0013726835964310226	0.5658111483402343	2	1
APC	dextran sulfate/adverse effects	0.0020566383584686987	0.004003380010759681	0.02127659574468085	0.8192464059779487	1	1
APC	phthalazines/administration & dosage	0.0020566383584686987	0.004003380010759681	0.02127659574468085	0.8192464059779487	1	1
APC	tumor microenvironment/drug effects	0.003954425372989068	0.007113781094266048	0.02127659574468085	0.8192464059779487	1	1
APC	b7-h1 antigen/genetics	0.003954425372989068	0.007113781094266048	0.02127659574468085	0.8192464059779487	1	1
APC	colorectal neoplasms/drug therapy	0.003954425372989068	0.007113781094266048	0.02127659574468085	0.8192464059779487	1	1
APC	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.0020566383584686987	0.004003380010759681	0.02127659574468085	0.8192464059779487	1	1
APC	colonic neoplasms/drug therapy	0.0020566383584686987	0.004003380010759681	0.02127659574468085	0.8192464059779487	1	1
APC	piperazines/administration & dosage	0.0020566383584686987	0.004003380010759681	0.02127659574468085	0.8192464059779487	1	1
APC	ARG1	0.0020566383584686987	0.004003380010759681	0.02127659574468085	0.8192464059779487	1	1
APC	MIR15B	0.003954425372989068	0.007113781094266048	0.02127659574468085	0.8192464059779487	1	1
APC	NRF1	0.003954425372989068	0.007113781094266048	0.02127659574468085	0.8192464059779487	1	1
APC	PARP1	0.0020566383584686987	0.004003380010759681	0.02127659574468085	0.8192464059779487	1	1
APC	TIPARP	0.0020566383584686987	0.004003380010759681	0.02127659574468085	0.8192464059779487	1	1
CD274	b7-h1 antigen/antagonists & inhibitors	0.00012922829913675216	0.0003533856973712794	0.0033944078063919306	0.32891616371986787	3	1
CD274	CTLA4	0.0011380941403548173	0.0024159334509092894	0.00032479323499700523	0.008727969937297866	7	1
CD274	PDCD1	0.00023341454193070987	0.0005549716381569326	1.345997632416698e-07	1.6855308710131873e-06	13	1
diarrhea/chemically induced	adrenal cortex hormones/therapeutic use	3.485816256731944e-05	0.00012093648237641439	0.00044761421622750735	0.16284051309402042	4	1
diarrhea/chemically induced	biological products/therapeutic use	0.0024322973565504835	0.004602863272136351	0.15957446808510636	0.8192464059779487	1	1
diarrhea/chemically induced	beclomethasone/adverse effects	0.0024322973565504835	0.004602863272136351	0.15957446808510636	0.8192464059779487	1	1
diarrhea/chemically induced	LTF	0.0024322973565504835	0.004602863272136351	0.15957446808510636	0.8192464059779487	1	1
diarrhea/chemically induced	feces	0.0024322973565504835	0.004602863272136351	0.1595744680851064	0.8192464059779487	1	1
CD8A	colitis ulcerative/immunology	0.0009078187726313525	0.00193314227157407	0.002287805994051705	0.5658111483402343	2	1
CD8A	cd8-positive t-lymphocytes/drug effects	0.0009078187726313525	0.00193314227157407	0.002287805994051705	0.5658111483402343	2	1
CD8A	CD4	0.00012630782726752443	0.00034586304379295284	0.002287805994051705	0.5658111483402343	2	1
CD8A	CD68	0.00012630782726752443	0.00034586304379295284	0.002287805994051705	0.5658111483402343	2	1
CD8A	phenotype	0.0009078187726313525	0.00193314227157407	0.002287805994051705	0.5658111483402343	2	1
ipilimumab/adverse effects	protein kinase inhibitors/therapeutic use	5.351348851490023e-05	0.00016451028899179036	0.09574468085106383	0.8192464059779487	1	1
ipilimumab/adverse effects	colitis/chemically induced	0.0005951113515921813	0.0013340957771956592	0.06114028197916452	0.0007106107119884933	9	1
ipilimumab/adverse effects	drug-related side effects and adverse reactions/diagnosis	1.2109095751888788e-05	4.920827755747635e-05	0.09574468085106383	0.8192464059779487	1	1
neoplasms	LTF	1.1102230246251565e-16	2.6962559169468086e-15	0.0425531914893617	0.8192464059779487	1	1
neoplasms	diarrhea	2.5376367673857203e-12	4.0762039413124957e-11	0.0837336993822924	0.8192464059779487	1	1
neoplasms	immune checkpoint inhibitors	0.0017558189730277896	0.003457404155382906	0.38176901729168156	0.5658111483402343	2	1
neoplasms	infliximab/adverse effects	0.00019844215462494486	0.00047626117109986763	0.16209570024735195	0.8192464059779487	1	1
neoplasms	colitis	1.550077231438074e-05	6.212490279241003e-05	0.16209570024735195	0.8192464059779487	1	1
neoplasms	recurrence	6.623193883703582e-05	0.0001911077160219987	0.08373369938229239	0.8192464059779487	1	1
neoplasms	inflammatory bowel diseases	1.0226270596991327e-07	7.268847392983382e-07	0.08373369938229239	0.8192464059779487	1	1
LTF	immune checkpoint inhibitors	0.004953734053108061	0.008833581703094794	0.3191489361702128	0.8192464059779487	1	1
LTF	infliximab/adverse effects	2.652003061598407e-10	2.6985880197116785e-09	0.0425531914893617	0.8192464059779487	1	1
adrenal gland diseases/diagnostic imaging	myocarditis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
adrenal gland diseases/diagnostic imaging	pancreatitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
adrenal gland diseases/diagnostic imaging	neoplasms/diagnostic imaging	7.525086331838793e-09	5.602619020785087e-08	0.02127659574468085	0.8192464059779487	1	1
adrenal gland diseases/diagnostic imaging	sarcoidosis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
adrenal gland diseases/diagnostic imaging	hepatitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
adrenal gland diseases/diagnostic imaging	pericarditis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
adrenal gland diseases/diagnostic imaging	encephalitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
adrenal gland diseases/diagnostic imaging	colitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
adrenal gland diseases/diagnostic imaging	pneumonia/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
adrenal gland diseases/diagnostic imaging	thyroiditis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
myocarditis/diagnostic imaging	thyroiditis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
myocarditis/diagnostic imaging	pancreatitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
myocarditis/diagnostic imaging	neoplasms/diagnostic imaging	7.525086331838793e-09	5.602619020785087e-08	0.02127659574468085	0.8192464059779487	1	1
myocarditis/diagnostic imaging	sarcoidosis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
myocarditis/diagnostic imaging	hepatitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
myocarditis/diagnostic imaging	pericarditis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
myocarditis/diagnostic imaging	encephalitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
myocarditis/diagnostic imaging	colitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
myocarditis/diagnostic imaging	pneumonia/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
IL17A	gene expression regulation neoplastic	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL17A	micrornas/genetics	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL17A	lymphocytes tumor-infiltrating/metabolism	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL17A	glucocorticoids	7.120456303022493e-06	2.9765841922471078e-05	0.02127659574468085	0.8192464059779487	1	1
IL17A	arthritis/chemically induced	7.120456303022493e-06	2.9765841922471078e-05	0.02127659574468085	0.8192464059779487	1	1
IL17A	ht29 cells	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL17A	t-lymphocytes cytotoxic/immunology	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL17A	tumor microenvironment/drug effects	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL17A	b7-h1 antigen/genetics	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL17A	colorectal neoplasms/drug therapy	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL17A	CHI3L1	7.120456303022493e-06	2.9765841922471078e-05	0.02127659574468085	0.8192464059779487	1	1
IL17A	CXCL8	7.120456303022493e-06	2.9765841922471078e-05	0.02127659574468085	0.8192464059779487	1	1
IL17A	MIR15B	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL17A	NRF1	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
colitis/chemically induced	immune checkpoint inhibitors/adverse effects	4.461248588738531e-05	0.00015399233707320817	0.3102181023015856	0.0	41	1
colitis/chemically induced	immune checkpoint inhibitors	2.454646976934871e-05	8.570536355370142e-05	0.8253264548783232	4.639690991511783e-13	21	1
immune checkpoint inhibitors/adverse effects	mycophenolic acid	0.005203711761547214	0.009135604125263612	0.5638297872340425	0.8192464059779487	1	1
immune checkpoint inhibitors/adverse effects	gastritis/chemically induced	0.005203711761547214	0.009135604125263612	0.5638297872340425	0.8192464059779487	1	1
immune checkpoint inhibitors/adverse effects	anti-bacterial agents	0.005203711761547214	0.009135604125263612	0.5638297872340425	0.8192464059779487	1	1
immune checkpoint inhibitors/adverse effects	adrenal cortex hormones/pharmacology	0.005203711761547214	0.009135604125263612	0.5638297872340425	0.8192464059779487	1	1
immune checkpoint inhibitors/adverse effects	antineoplastic agents immunological/adverse effects	0.0032218971822106646	0.005969727749055183	0.015059111849064102	0.008727969937297866	7	1
MIR15B	gene expression regulation neoplastic	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
MIR15B	micrornas/genetics	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
MIR15B	lymphocytes tumor-infiltrating/metabolism	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
MIR15B	ht29 cells	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
MIR15B	t-lymphocytes cytotoxic/immunology	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
MIR15B	tumor microenvironment/drug effects	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
MIR15B	b7-h1 antigen/genetics	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
MIR15B	colorectal neoplasms/drug therapy	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
MIR15B	NRF1	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
NRF1	gene expression regulation neoplastic	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
NRF1	micrornas/genetics	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
NRF1	lymphocytes tumor-infiltrating/metabolism	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
NRF1	ht29 cells	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
NRF1	t-lymphocytes cytotoxic/immunology	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
NRF1	tumor microenvironment/drug effects	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
NRF1	b7-h1 antigen/genetics	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
NRF1	colorectal neoplasms/drug therapy	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
paclitaxel/therapeutic use	hashimoto disease/chemically induced	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
paclitaxel/therapeutic use	squamous cell carcinoma of head and neck/drug therapy	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
paclitaxel/therapeutic use	tongue neoplasms/drug therapy	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
paclitaxel/therapeutic use	colitis ulcerative/chemically induced	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
paclitaxel/therapeutic use	antineoplastic agents immunological/adverse effects	0.0006419394159206115	0.0014203431762234789	0.07446808510638298	0.8192464059779487	1	1
paclitaxel/therapeutic use	SNCA	9.92822662526649e-07	6.212755311516454e-06	0.031914893617021274	0.8192464059779487	1	1
PDCD1	inflammatory bowel diseases/complications	0.005395623088964685	0.009464377559318966	0.06863417982155114	0.5658111483402343	2	1
PDCD1	CTLA4	0.0006321190561746626	0.0014077760639697725	6.54938016501819e-07	4.0365872528276203e-05	11	1
pancreatitis/diagnostic imaging	thyroiditis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
pancreatitis/diagnostic imaging	neoplasms/diagnostic imaging	7.525086331838793e-09	5.602619020785087e-08	0.02127659574468085	0.8192464059779487	1	1
pancreatitis/diagnostic imaging	sarcoidosis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
pancreatitis/diagnostic imaging	hepatitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
pancreatitis/diagnostic imaging	pericarditis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
pancreatitis/diagnostic imaging	encephalitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
pancreatitis/diagnostic imaging	colitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
pancreatitis/diagnostic imaging	pneumonia/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
neoplasms/diagnostic imaging	thyroiditis/diagnostic imaging	7.525086331838793e-09	5.602619020785087e-08	0.02127659574468085	0.8192464059779487	1	1
neoplasms/diagnostic imaging	sarcoidosis/diagnostic imaging	7.525086331838793e-09	5.602619020785087e-08	0.02127659574468085	0.8192464059779487	1	1
neoplasms/diagnostic imaging	hepatitis/diagnostic imaging	7.525086331838793e-09	5.602619020785087e-08	0.02127659574468085	0.8192464059779487	1	1
neoplasms/diagnostic imaging	pericarditis/diagnostic imaging	7.525086331838793e-09	5.602619020785087e-08	0.02127659574468085	0.8192464059779487	1	1
neoplasms/diagnostic imaging	encephalitis/diagnostic imaging	7.525086331838793e-09	5.602619020785087e-08	0.02127659574468085	0.8192464059779487	1	1
neoplasms/diagnostic imaging	colitis/diagnostic imaging	7.525086331838793e-09	5.602619020785087e-08	0.02127659574468085	0.8192464059779487	1	1
neoplasms/diagnostic imaging	pneumonia/diagnostic imaging	7.525086331838793e-09	5.602619020785087e-08	0.02127659574468085	0.8192464059779487	1	1
colitis ulcerative	immune checkpoint inhibitors	8.899991854605105e-11	1.0257617730731307e-09	0.31914893617021284	0.8192464059779487	1	1
immune checkpoint inhibitors	diarrhea	2.907247912076194e-06	1.7972078001925563e-05	0.09951956074124915	0.5658111483402343	2	1
immune checkpoint inhibitors	ulcer/chemically induced	0.00022720288091671037	0.0005408329954143397	0.31914893617021284	0.8192464059779487	1	1
immune checkpoint inhibitors	esophagitis	0.00022720288091671037	0.0005408329954143397	0.31914893617021284	0.8192464059779487	1	1
immune checkpoint inhibitors	prednisolone/therapeutic use	0.0015382182274216172	0.003061429447746438	0.31914893617021284	0.8192464059779487	1	1
immune checkpoint inhibitors	carcinoma non-small-cell lung	0.00022720288091671037	0.0005408329954143397	0.31914893617021284	0.8192464059779487	1	1
immune checkpoint inhibitors	colitis/therapy	5.349388721098691e-06	2.346828600223942e-05	0.31914893617021284	0.8192464059779487	1	1
immune checkpoint inhibitors	neoplasm recurrence local/drug therapy	0.004953734053108061	0.008833581703094794	0.31914893617021284	0.8192464059779487	1	1
immune checkpoint inhibitors	diarrhea/therapy	0.00022720288091671037	0.0005408329954143397	0.3191489361702128	0.8192464059779487	1	1
immune checkpoint inhibitors	colitis	3.5965473903165623e-05	0.00012456632727072644	0.09419409929690137	0.32891616371986787	3	1
immune checkpoint inhibitors	colitis microscopic/chemically induced	2.389425324267336e-10	2.6985880197116785e-09	0.09951956074124914	0.5658111483402343	2	1
immune checkpoint inhibitors	immunologic factors	2.389425324267336e-10	2.6985880197116785e-09	0.09951956074124914	0.5658111483402343	2	1
immune checkpoint inhibitors	neoplasms/therapy	0.00022720288091671037	0.0005408329954143397	0.3191489361702128	0.8192464059779487	1	1
immune checkpoint inhibitors	endometrial neoplasms/drug therapy	0.004953734053108061	0.008833581703094794	0.3191489361702128	0.8192464059779487	1	1
immune checkpoint inhibitors	antibodies monoclonal humanized	0.004953734053108061	0.008833581703094794	0.3191489361702128	0.8192464059779487	1	1
immune checkpoint inhibitors	crohn disease/drug therapy	5.349388721098691e-06	2.346828600223942e-05	0.3191489361702128	0.8192464059779487	1	1
immune checkpoint inhibitors	lung neoplasms	0.00022720288091671037	0.0005408329954143397	0.3191489361702128	0.8192464059779487	1	1
immune checkpoint inhibitors	cd8-positive t-lymphocytes	0.00022720288091671037	0.0005408329954143397	0.3191489361702128	0.8192464059779487	1	1
immune checkpoint inhibitors	beclomethasone/adverse effects	0.004953734053108061	0.008833581703094794	0.3191489361702128	0.8192464059779487	1	1
immune checkpoint inhibitors	cytomegalovirus infections/complications	5.349388721098691e-06	2.346828600223942e-05	0.3191489361702128	0.8192464059779487	1	1
immune checkpoint inhibitors	TNF	0.0004006535029962288	0.0009132213923042534	0.030288561964728	0.32891616371986787	3	1
nephritis/chemically induced	nivolumab/therapeutic use	0.002202012356660288	0.004217939162053509	0.02127659574468085	0.8192464059779487	1	1
nephritis/chemically induced	diabetes mellitus type 1/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
nephritis/chemically induced	exanthema/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
nephritis/chemically induced	bevacizumab/administration & dosage	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
nephritis/chemically induced	pneumonia/chemically induced	0.005203711761547214	0.009135604125263612	0.031914893617021274	0.8192464059779487	1	1
nephritis/chemically induced	fatigue/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
nephritis/chemically induced	pruritus/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
nephritis/chemically induced	adrenal insufficiency/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
nephritis/chemically induced	axitinib/administration & dosage	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
nephritis/chemically induced	hypophysitis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
nephritis/chemically induced	angiogenesis inhibitors/therapeutic use	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
nephritis/chemically induced	myocarditis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
nephritis/chemically induced	hepatitis autoimmune/etiology	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
nephritis/chemically induced	myasthenia gravis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
nephritis/chemically induced	ipilimumab/therapeutic use	0.0026775126805036464	0.004970087232236068	0.031914893617021274	0.8192464059779487	1	1
nephritis/chemically induced	carcinoma renal cell/drug therapy	0.0008560312541340265	0.0018343526874300567	0.02127659574468085	0.8192464059779487	1	1
nivolumab/therapeutic use	diabetes mellitus type 1/chemically induced	0.002202012356660288	0.004217939162053509	0.02127659574468085	0.8192464059779487	1	1
nivolumab/therapeutic use	exanthema/chemically induced	0.002202012356660288	0.004217939162053509	0.02127659574468085	0.8192464059779487	1	1
nivolumab/therapeutic use	bevacizumab/administration & dosage	0.002202012356660288	0.004217939162053509	0.02127659574468085	0.8192464059779487	1	1
nivolumab/therapeutic use	arthritis/chemically induced	1.0654911658636301e-05	4.347203956723611e-05	0.02127659574468085	0.8192464059779487	1	1
nivolumab/therapeutic use	fatigue/chemically induced	0.002202012356660288	0.004217939162053509	0.02127659574468085	0.8192464059779487	1	1
nivolumab/therapeutic use	glucocorticoids	1.0654911658636301e-05	4.347203956723611e-05	0.02127659574468085	0.8192464059779487	1	1
nivolumab/therapeutic use	pruritus/chemically induced	0.002202012356660288	0.004217939162053509	0.02127659574468085	0.8192464059779487	1	1
nivolumab/therapeutic use	adrenal insufficiency/chemically induced	0.002202012356660288	0.004217939162053509	0.02127659574468085	0.8192464059779487	1	1
nivolumab/therapeutic use	axitinib/administration & dosage	0.002202012356660288	0.004217939162053509	0.02127659574468085	0.8192464059779487	1	1
nivolumab/therapeutic use	hypophysitis/chemically induced	0.002202012356660288	0.004217939162053509	0.02127659574468085	0.8192464059779487	1	1
nivolumab/therapeutic use	angiogenesis inhibitors/therapeutic use	0.002202012356660288	0.004217939162053509	0.02127659574468085	0.8192464059779487	1	1
nivolumab/therapeutic use	myocarditis/chemically induced	0.002202012356660288	0.004217939162053509	0.02127659574468085	0.8192464059779487	1	1
nivolumab/therapeutic use	hepatitis autoimmune/etiology	0.002202012356660288	0.004217939162053509	0.02127659574468085	0.8192464059779487	1	1
nivolumab/therapeutic use	myasthenia gravis/chemically induced	0.002202012356660288	0.004217939162053509	0.02127659574468085	0.8192464059779487	1	1
nivolumab/therapeutic use	CHI3L1	1.0654911658636301e-05	4.347203956723611e-05	0.02127659574468085	0.8192464059779487	1	1
nivolumab/therapeutic use	CXCL8	1.0654911658636301e-05	4.347203956723611e-05	0.02127659574468085	0.8192464059779487	1	1
disease susceptibility	colitis/diagnosis	0.0	0.0	0.02127659574468085	0.8192464059779487	1	1
disease susceptibility	postoperative complications	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
colitis ulcerative/chemically induced	hashimoto disease/chemically induced	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
colitis ulcerative/chemically induced	squamous cell carcinoma of head and neck/drug therapy	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
colitis ulcerative/chemically induced	tongue neoplasms/drug therapy	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
colitis ulcerative/chemically induced	antineoplastic agents immunological/adverse effects	0.0006419394159206115	0.0014203431762234789	0.07446808510638298	0.8192464059779487	1	1
colitis ulcerative/chemically induced	SNCA	9.92822662526649e-07	6.212755311516454e-06	0.031914893617021274	0.8192464059779487	1	1
melanoma/drug therapy	intestinal mucosa/diagnostic imaging	0.00010409344358552897	0.0002861868260302953	0.05319148936170214	0.8192464059779487	1	1
melanoma/drug therapy	vitamin d	5.181838291790086e-10	4.404562548021573e-09	0.05319148936170214	0.8192464059779487	1	1
melanoma/drug therapy	colon/diagnostic imaging	0.00010409344358552897	0.0002861868260302953	0.05319148936170214	0.8192464059779487	1	1
melanoma/drug therapy	drug resistance/immunology	0.00010409344358552897	0.0002861868260302953	0.05319148936170214	0.8192464059779487	1	1
melanoma/drug therapy	skin neoplasms/drug therapy	1.2991642983628537e-08	9.499265837491833e-08	0.002287805994051705	0.5658111483402343	2	1
melanoma/drug therapy	infliximab/adverse effects	1.1618009454483769e-06	7.247932503714644e-06	0.013134935846881177	0.5658111483402343	2	1
melanoma/drug therapy	tumor necrosis factor inhibitors	1.316505098991616e-05	5.2971802799662655e-05	0.05319148936170214	0.8192464059779487	1	1
melanoma/drug therapy	TNF	6.451230186721446e-07	4.138525025443947e-06	0.0067142132434126105	0.5658111483402343	2	1
melanoma/drug therapy	glucocorticoids/pharmacology	0.00010409344358552897	0.0002861868260302953	0.05319148936170214	0.8192464059779487	1	1
melanoma/drug therapy	immunosuppressive agents/pharmacology	0.00010409344358552897	0.0002861868260302953	0.05319148936170213	0.8192464059779487	1	1
melanoma/drug therapy	drug-related side effects and adverse reactions	0.0007200871327536218	0.0015880840549377172	0.10409517272935256	0.8192464059779487	1	1
melanoma/drug therapy	mucositis/chemically induced	0.00010409344358552897	0.0002861868260302953	0.05319148936170213	0.8192464059779487	1	1
diabetes mellitus type 1/chemically induced	carcinoma renal cell/drug therapy	0.0008560312541340265	0.0018343526874300567	0.02127659574468085	0.8192464059779487	1	1
diabetes mellitus type 1/chemically induced	exanthema/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
diabetes mellitus type 1/chemically induced	bevacizumab/administration & dosage	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
diabetes mellitus type 1/chemically induced	pneumonia/chemically induced	0.005203711761547214	0.009135604125263612	0.031914893617021274	0.8192464059779487	1	1
diabetes mellitus type 1/chemically induced	fatigue/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
diabetes mellitus type 1/chemically induced	pruritus/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
diabetes mellitus type 1/chemically induced	adrenal insufficiency/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
diabetes mellitus type 1/chemically induced	axitinib/administration & dosage	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
diabetes mellitus type 1/chemically induced	hypophysitis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
diabetes mellitus type 1/chemically induced	angiogenesis inhibitors/therapeutic use	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
diabetes mellitus type 1/chemically induced	myocarditis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
diabetes mellitus type 1/chemically induced	hepatitis autoimmune/etiology	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
diabetes mellitus type 1/chemically induced	myasthenia gravis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
diabetes mellitus type 1/chemically induced	ipilimumab/therapeutic use	0.0026775126805036464	0.004970087232236068	0.031914893617021274	0.8192464059779487	1	1
sarcoidosis/diagnostic imaging	thyroiditis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
sarcoidosis/diagnostic imaging	hepatitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
sarcoidosis/diagnostic imaging	pericarditis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
sarcoidosis/diagnostic imaging	encephalitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
sarcoidosis/diagnostic imaging	colitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
sarcoidosis/diagnostic imaging	pneumonia/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
piperidines/therapeutic use	colitis ulcerative/immunology	0.001617782544867441	0.003197942239854244	0.04232441088995653	0.8192464059779487	1	1
piperidines/therapeutic use	interferon-gamma/metabolism	2.117447749905299e-05	7.4092511317441e-05	0.02127659574468085	0.8192464059779487	1	1
piperidines/therapeutic use	pyrimidines/therapeutic use	1.1320056003683021e-11	1.391139412500805e-10	0.00022878059940517045	0.5658111483402343	2	1
piperidines/therapeutic use	immunologic memory/drug effects	2.117447749905299e-05	7.4092511317441e-05	0.02127659574468085	0.8192464059779487	1	1
piperidines/therapeutic use	protein kinase inhibitors/therapeutic use	5.172982153744954e-09	3.997304391530191e-08	0.02127659574468085	0.8192464059779487	1	1
piperidines/therapeutic use	cd8-positive t-lymphocytes/drug effects	0.001617782544867441	0.003197942239854244	0.04232441088995653	0.8192464059779487	1	1
piperidines/therapeutic use	phenotype	0.001617782544867441	0.003197942239854244	0.04232441088995653	0.8192464059779487	1	1
hepatitis/diagnostic imaging	thyroiditis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
hepatitis/diagnostic imaging	pericarditis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
hepatitis/diagnostic imaging	encephalitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
hepatitis/diagnostic imaging	colitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
hepatitis/diagnostic imaging	pneumonia/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
diarrhea	colitis	0.0	0.0	0.0013726835964310228	0.5658111483402343	2	1
diarrhea	recurrence	1.2115495051645553e-08	8.890507160200334e-08	0.04232441088995653	0.8192464059779487	1	1
diarrhea	inflammatory bowel diseases	3.7636560534792807e-14	6.451981805964481e-13	0.04232441088995653	0.8192464059779487	1	1
exanthema/chemically induced	carcinoma renal cell/drug therapy	0.0008560312541340265	0.0018343526874300567	0.02127659574468085	0.8192464059779487	1	1
exanthema/chemically induced	bevacizumab/administration & dosage	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
exanthema/chemically induced	pneumonia/chemically induced	0.005203711761547214	0.009135604125263612	0.031914893617021274	0.8192464059779487	1	1
exanthema/chemically induced	fatigue/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
exanthema/chemically induced	pruritus/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
exanthema/chemically induced	adrenal insufficiency/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
exanthema/chemically induced	axitinib/administration & dosage	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
exanthema/chemically induced	hypophysitis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
exanthema/chemically induced	angiogenesis inhibitors/therapeutic use	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
exanthema/chemically induced	myocarditis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
exanthema/chemically induced	hepatitis autoimmune/etiology	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
exanthema/chemically induced	myasthenia gravis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
exanthema/chemically induced	ipilimumab/therapeutic use	0.0026775126805036464	0.004970087232236068	0.031914893617021274	0.8192464059779487	1	1
bevacizumab/administration & dosage	carcinoma renal cell/drug therapy	0.0008560312541340265	0.0018343526874300567	0.02127659574468085	0.8192464059779487	1	1
bevacizumab/administration & dosage	pneumonia/chemically induced	0.005203711761547214	0.009135604125263612	0.031914893617021274	0.8192464059779487	1	1
bevacizumab/administration & dosage	fatigue/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
bevacizumab/administration & dosage	pruritus/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
bevacizumab/administration & dosage	adrenal insufficiency/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
bevacizumab/administration & dosage	axitinib/administration & dosage	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
bevacizumab/administration & dosage	hypophysitis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
bevacizumab/administration & dosage	angiogenesis inhibitors/therapeutic use	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
bevacizumab/administration & dosage	myocarditis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
bevacizumab/administration & dosage	hepatitis autoimmune/etiology	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
bevacizumab/administration & dosage	myasthenia gravis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
bevacizumab/administration & dosage	ipilimumab/therapeutic use	0.0026775126805036464	0.004970087232236068	0.031914893617021274	0.8192464059779487	1	1
programmed cell death 1 receptor/antagonists & inhibitors	colitis/epidemiology	0.0019176743925015671	0.0037724742147571813	0.08510638297872342	0.8192464059779487	1	1
programmed cell death 1 receptor/antagonists & inhibitors	b7-h1 antigen/antagonists & inhibitors	0.0016436790675965485	0.003245987703675662	0.01838202381307631	0.5658111483402343	2	1
programmed cell death 1 receptor/antagonists & inhibitors	ctla-4 antigen/antagonists & inhibitors	0.0002898938954964958	0.0006750953730740313	0.00041777326847900685	0.32891616371986787	3	1
programmed cell death 1 receptor/antagonists & inhibitors	antineoplastic agents immunological/adverse effects	0.0034263021182761033	0.006319761592480336	0.012337984124876841	0.32891616371986787	3	1
arthritis/chemically induced	glucocorticoids	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
arthritis/chemically induced	CHI3L1	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
arthritis/chemically induced	CXCL8	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
arthritis/chemically induced	IL6	7.120456303022493e-06	2.9765841922471078e-05	0.02127659574468085	0.8192464059779487	1	1
pneumonia/chemically induced	fatigue/chemically induced	0.005203711761547214	0.009135604125263612	0.031914893617021274	0.8192464059779487	1	1
pneumonia/chemically induced	pruritus/chemically induced	0.005203711761547214	0.009135604125263612	0.031914893617021274	0.8192464059779487	1	1
pneumonia/chemically induced	antibodies monoclonal humanized/administration & dosage	5.520278016424296e-05	0.00016451028899179036	0.031914893617021274	0.8192464059779487	1	1
pneumonia/chemically induced	adrenal insufficiency/chemically induced	0.005203711761547214	0.009135604125263612	0.031914893617021274	0.8192464059779487	1	1
pneumonia/chemically induced	axitinib/administration & dosage	0.005203711761547214	0.009135604125263612	0.031914893617021274	0.8192464059779487	1	1
pneumonia/chemically induced	hypophysitis/chemically induced	0.005203711761547214	0.009135604125263612	0.031914893617021274	0.8192464059779487	1	1
pneumonia/chemically induced	angiogenesis inhibitors/therapeutic use	0.005203711761547214	0.009135604125263612	0.031914893617021274	0.8192464059779487	1	1
pneumonia/chemically induced	myocarditis/chemically induced	0.005203711761547214	0.009135604125263612	0.031914893617021274	0.8192464059779487	1	1
pneumonia/chemically induced	hepatitis autoimmune/etiology	0.005203711761547214	0.009135604125263612	0.031914893617021274	0.8192464059779487	1	1
pneumonia/chemically induced	dose-response relationship drug	0.0013870264227533458	0.0028393358596311784	0.06314344543582703	0.8192464059779487	1	1
pneumonia/chemically induced	myasthenia gravis/chemically induced	0.005203711761547214	0.009135604125263612	0.031914893617021274	0.8192464059779487	1	1
pneumonia/chemically induced	ipilimumab/therapeutic use	1.1631799658906594e-05	4.736301657518853e-05	0.0020441049207722837	0.5658111483402343	2	1
pneumonia/chemically induced	drugs investigational/administration & dosage	5.520278016424296e-05	0.00016451028899179036	0.031914893617021274	0.8192464059779487	1	1
pneumonia/chemically induced	neoplasms/diagnosis	5.520278016424296e-05	0.00016451028899179036	0.031914893617021274	0.8192464059779487	1	1
postoperative complications	colitis/diagnosis	0.0	0.0	0.02127659574468085	0.8192464059779487	1	1
fatigue/chemically induced	carcinoma renal cell/drug therapy	0.0008560312541340265	0.0018343526874300567	0.02127659574468085	0.8192464059779487	1	1
fatigue/chemically induced	pruritus/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
fatigue/chemically induced	adrenal insufficiency/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
fatigue/chemically induced	axitinib/administration & dosage	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
fatigue/chemically induced	hypophysitis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
fatigue/chemically induced	angiogenesis inhibitors/therapeutic use	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
fatigue/chemically induced	myocarditis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
fatigue/chemically induced	hepatitis autoimmune/etiology	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
fatigue/chemically induced	myasthenia gravis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
fatigue/chemically induced	ipilimumab/therapeutic use	0.0026775126805036464	0.004970087232236068	0.031914893617021274	0.8192464059779487	1	1
pericarditis/diagnostic imaging	thyroiditis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
pericarditis/diagnostic imaging	encephalitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
pericarditis/diagnostic imaging	colitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
pericarditis/diagnostic imaging	pneumonia/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
encephalitis/diagnostic imaging	thyroiditis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
encephalitis/diagnostic imaging	colitis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
encephalitis/diagnostic imaging	pneumonia/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
pruritus/chemically induced	carcinoma renal cell/drug therapy	0.0008560312541340265	0.0018343526874300567	0.02127659574468085	0.8192464059779487	1	1
pruritus/chemically induced	adrenal insufficiency/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
pruritus/chemically induced	axitinib/administration & dosage	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
pruritus/chemically induced	hypophysitis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
pruritus/chemically induced	angiogenesis inhibitors/therapeutic use	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
pruritus/chemically induced	myocarditis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
pruritus/chemically induced	hepatitis autoimmune/etiology	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
pruritus/chemically induced	myasthenia gravis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
pruritus/chemically induced	ipilimumab/therapeutic use	0.0026775126805036464	0.004970087232236068	0.031914893617021274	0.8192464059779487	1	1
glucocorticoids	CHI3L1	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
glucocorticoids	CXCL8	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
glucocorticoids	IL6	7.120456303022493e-06	2.9765841922471078e-05	0.02127659574468085	0.8192464059779487	1	1
adrenal insufficiency/chemically induced	carcinoma renal cell/drug therapy	0.0008560312541340265	0.0018343526874300567	0.02127659574468085	0.8192464059779487	1	1
adrenal insufficiency/chemically induced	axitinib/administration & dosage	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
adrenal insufficiency/chemically induced	hypophysitis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
adrenal insufficiency/chemically induced	angiogenesis inhibitors/therapeutic use	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
adrenal insufficiency/chemically induced	myocarditis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
adrenal insufficiency/chemically induced	hepatitis autoimmune/etiology	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
adrenal insufficiency/chemically induced	myasthenia gravis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
adrenal insufficiency/chemically induced	ipilimumab/therapeutic use	0.0026775126805036464	0.004970087232236068	0.031914893617021274	0.8192464059779487	1	1
antineoplastic agents immunological/adverse effects	hashimoto disease/chemically induced	0.0006419394159206115	0.0014203431762234789	0.07446808510638298	0.8192464059779487	1	1
antineoplastic agents immunological/adverse effects	vitamin d	2.0197572914160133e-07	1.4014642430233563e-06	0.07446808510638298	0.8192464059779487	1	1
antineoplastic agents immunological/adverse effects	host microbial interactions/drug effects	9.862003890537263e-05	0.0002744677753983086	0.07446808510638298	0.8192464059779487	1	1
antineoplastic agents immunological/adverse effects	metabolome/drug effects	9.862003890537263e-05	0.0002744677753983086	0.07446808510638298	0.8192464059779487	1	1
antineoplastic agents immunological/adverse effects	lymphocytes/drug effects	0.0021528361907772187	0.004174701358541374	0.07446808510638298	0.8192464059779487	1	1
antineoplastic agents immunological/adverse effects	squamous cell carcinoma of head and neck/drug therapy	0.0006419394159206115	0.0014203431762234789	0.07446808510638298	0.8192464059779487	1	1
antineoplastic agents immunological/adverse effects	tongue neoplasms/drug therapy	0.0006419394159206115	0.0014203431762234789	0.07446808510638298	0.8192464059779487	1	1
antineoplastic agents immunological/adverse effects	dysbiosis/etiology	9.862003890537263e-05	0.0002744677753983086	0.07446808510638298	0.8192464059779487	1	1
antineoplastic agents immunological/adverse effects	cytomegalovirus infections/diagnosis	1.7539318886150568e-09	1.4086697058168173e-08	0.07446808510638298	0.8192464059779487	1	1
antineoplastic agents immunological/adverse effects	vitamin d/administration & dosage	0.0021528361907772187	0.004174701358541374	0.07446808510638298	0.8192464059779487	1	1
antineoplastic agents immunological/adverse effects	anti-bacterial agents/pharmacology	9.862003890537263e-05	0.0002744677753983086	0.07446808510638298	0.8192464059779487	1	1
antineoplastic agents immunological/adverse effects	ctla-4 antigen/antagonists & inhibitors	0.0007374227619380003	0.0016245598643126573	0.013890961176926982	0.5658111483402343	2	1
antineoplastic agents immunological/adverse effects	neutrophils/drug effects	0.0021528361907772187	0.004174701358541374	0.07446808510638298	0.8192464059779487	1	1
antineoplastic agents immunological/adverse effects	antibodies monoclonal/adverse effects	0.0021528361907772187	0.004174701358541374	0.07446808510638298	0.8192464059779487	1	1
axitinib/administration & dosage	carcinoma renal cell/drug therapy	0.0008560312541340265	0.0018343526874300567	0.02127659574468085	0.8192464059779487	1	1
axitinib/administration & dosage	hypophysitis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
axitinib/administration & dosage	angiogenesis inhibitors/therapeutic use	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
axitinib/administration & dosage	myocarditis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
axitinib/administration & dosage	hepatitis autoimmune/etiology	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
axitinib/administration & dosage	myasthenia gravis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
axitinib/administration & dosage	ipilimumab/therapeutic use	0.0026775126805036464	0.004970087232236068	0.031914893617021274	0.8192464059779487	1	1
ipilimumab/therapeutic use	carcinoma renal cell/drug therapy	1.4259522129744795e-07	9.962131898862802e-07	0.0006863417982155114	0.5658111483402343	2	1
ipilimumab/therapeutic use	proton pump inhibitors/adverse effects	5.172982153744954e-09	3.997304391530191e-08	0.031914893617021274	0.8192464059779487	1	1
ipilimumab/therapeutic use	angiogenesis inhibitors/therapeutic use	0.0026775126805036464	0.004970087232236068	0.031914893617021274	0.8192464059779487	1	1
ipilimumab/therapeutic use	hypophysitis/chemically induced	0.0026775126805036464	0.004970087232236068	0.031914893617021274	0.8192464059779487	1	1
ipilimumab/therapeutic use	inflammatory bowel diseases/drug therapy	0.0026775126805036464	0.004970087232236068	0.09369311569335442	0.8192464059779487	1	1
ipilimumab/therapeutic use	myocarditis/chemically induced	0.0026775126805036464	0.004970087232236068	0.031914893617021274	0.8192464059779487	1	1
ipilimumab/therapeutic use	hepatitis autoimmune/etiology	0.0026775126805036464	0.004970087232236068	0.031914893617021274	0.8192464059779487	1	1
ipilimumab/therapeutic use	myasthenia gravis/chemically induced	0.0026775126805036464	0.004970087232236068	0.031914893617021274	0.8192464059779487	1	1
colitis/diagnostic imaging	thyroiditis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
colitis/diagnostic imaging	pneumonia/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
hypophysitis/chemically induced	carcinoma renal cell/drug therapy	0.0008560312541340265	0.0018343526874300567	0.02127659574468085	0.8192464059779487	1	1
hypophysitis/chemically induced	angiogenesis inhibitors/therapeutic use	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
hypophysitis/chemically induced	myocarditis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
hypophysitis/chemically induced	hepatitis autoimmune/etiology	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
hypophysitis/chemically induced	myasthenia gravis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
angiogenesis inhibitors/therapeutic use	carcinoma renal cell/drug therapy	0.0008560312541340265	0.0018343526874300567	0.02127659574468085	0.8192464059779487	1	1
angiogenesis inhibitors/therapeutic use	myocarditis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
angiogenesis inhibitors/therapeutic use	hepatitis autoimmune/etiology	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
angiogenesis inhibitors/therapeutic use	myasthenia gravis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
myocarditis/chemically induced	carcinoma renal cell/drug therapy	0.0008560312541340265	0.0018343526874300567	0.02127659574468085	0.8192464059779487	1	1
myocarditis/chemically induced	hepatitis autoimmune/etiology	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
myocarditis/chemically induced	myasthenia gravis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
CTLA4	colitis	0.0032722532421199935	0.006052036821328003	0.07795406527166249	0.5658111483402343	2	1
CTLA4	inflammatory bowel diseases/drug therapy	0.0032722532421199935	0.006052036821328003	0.042016054429888705	0.5658111483402343	2	1
CTLA4	ctla-4 antigen/antagonists & inhibitors	0.0016744101947464562	0.003300286760659682	0.0016412521261675271	0.32891616371986787	3	1
colitis	pneumonia	2.649280794742026e-11	3.1421702449265886e-10	0.0425531914893617	0.8192464059779487	1	1
colitis	inflammatory bowel diseases/drug therapy	0.00014918924112905518	0.00036756769553535334	0.12357136462654053	0.8192464059779487	1	1
colitis	recurrence	0.0004688232400196224	0.0010544646192282576	0.08373369938229239	0.8192464059779487	1	1
colitis	inflammatory bowel diseases	2.88164700534832e-06	1.786796319425706e-05	0.08373369938229239	0.8192464059779487	1	1
colitis	ligands	2.649280794742026e-11	3.1421702449265886e-10	0.0425531914893617	0.8192464059779487	1	1
hepatitis autoimmune/etiology	carcinoma renal cell/drug therapy	0.0008560312541340265	0.0018343526874300567	0.02127659574468085	0.8192464059779487	1	1
hepatitis autoimmune/etiology	myasthenia gravis/chemically induced	0.00014918924112905518	0.00036756769553535334	0.010638297872340427	0.8192464059779487	1	1
myasthenia gravis/chemically induced	carcinoma renal cell/drug therapy	0.0008560312541340265	0.0018343526874300567	0.02127659574468085	0.8192464059779487	1	1
SNCA	hashimoto disease/chemically induced	9.92822662526649e-07	6.212755311516454e-06	0.031914893617021274	0.8192464059779487	1	1
SNCA	skin neoplasms/drug therapy	0.0006419394159206115	0.0014203431762234789	0.06314344543582705	0.8192464059779487	1	1
SNCA	squamous cell carcinoma of head and neck/drug therapy	9.92822662526649e-07	6.212755311516454e-06	0.031914893617021274	0.8192464059779487	1	1
SNCA	tumor necrosis factor inhibitors	2.0197572914160133e-07	1.4014642430233563e-06	0.031914893617021274	0.8192464059779487	1	1
SNCA	tongue neoplasms/drug therapy	9.92822662526649e-07	6.212755311516454e-06	0.031914893617021274	0.8192464059779487	1	1
SNCA	TNF	0.0027340602065619724	0.005070438928533112	0.09369311569335442	0.8192464059779487	1	1
immune checkpoint inhibitors/therapeutic use	sirolimus/therapeutic use	0.0024322973565504835	0.004602863272136351	0.02127659574468085	0.8192464059779487	1	1
immune checkpoint inhibitors/therapeutic use	drug-related side effects and adverse reactions/prevention & control	0.0024322973565504835	0.004602863272136351	0.02127659574468085	0.8192464059779487	1	1
immune checkpoint inhibitors/therapeutic use	growth inhibitors/therapeutic use	0.0024322973565504835	0.004602863272136351	0.02127659574468085	0.8192464059779487	1	1
immune checkpoint inhibitors/therapeutic use	cd8-positive t-lymphocytes/immunology	0.0024322973565504835	0.004602863272136351	0.02127659574468085	0.8192464059779487	1	1
immune checkpoint inhibitors/therapeutic use	cytotoxicity immunologic	0.0024322973565504835	0.004602863272136351	0.02127659574468085	0.8192464059779487	1	1
immune checkpoint inhibitors/therapeutic use	MTOR	0.0024322973565504835	0.004602863272136351	0.02127659574468085	0.8192464059779487	1	1
immune checkpoint inhibitors/therapeutic use	phosphatidylinositol 3-kinases/metabolism	0.0024322973565504835	0.004602863272136351	0.02127659574468085	0.8192464059779487	1	1
immune checkpoint inhibitors/therapeutic use	lymphocytes tumor-infiltrating/immunology	0.0024322973565504835	0.004602863272136351	0.02127659574468085	0.8192464059779487	1	1
recurrence	inflammatory bowel diseases	1.550077231438074e-05	6.212490279241003e-05	0.04232441088995653	0.8192464059779487	1	1
recurrence	biomarkers/analysis	0.0016585720850001984	0.0032722311928437184	0.04232441088995653	0.8192464059779487	1	1
recurrence	antineoplastic agents/adverse effects	0.00019844215462494486	0.00047626117109986763	0.02127659574468085	0.8192464059779487	1	1
recurrence	intestinal mucosa/chemistry	0.00019844215462494486	0.00047626117109986763	0.02127659574468085	0.8192464059779487	1	1
recurrence	leukemia lymphocytic chronic b-cell/drug therapy	0.00019844215462494486	0.00047626117109986763	0.02127659574468085	0.8192464059779487	1	1
recurrence	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.00019844215462494486	0.00047626117109986763	0.02127659574468085	0.8192464059779487	1	1
recurrence	purines/adverse effects	0.00019844215462494486	0.00047626117109986763	0.02127659574468085	0.8192464059779487	1	1
recurrence	colon/chemistry	0.00019844215462494486	0.00047626117109986763	0.02127659574468085	0.8192464059779487	1	1
recurrence	lymphocytosis/chemically induced	0.00019844215462494486	0.00047626117109986763	0.02127659574468085	0.8192464059779487	1	1
recurrence	protein kinase inhibitors/adverse effects	0.00019844215462494486	0.00047626117109986763	0.02127659574468085	0.8192464059779487	1	1
recurrence	apoptosis/drug effects	0.00019844215462494486	0.00047626117109986763	0.02127659574468085	0.8192464059779487	1	1
recurrence	quinazolinones/adverse effects	0.00019844215462494486	0.00047626117109986763	0.02127659574468085	0.8192464059779487	1	1
recurrence	lymphoma non-hodgkin/drug therapy	0.00019844215462494486	0.00047626117109986763	0.02127659574468085	0.8192464059779487	1	1
recurrence	PIK3CD	0.00019844215462494486	0.00047626117109986763	0.02127659574468085	0.8192464059779487	1	1
pneumonia/diagnostic imaging	thyroiditis/diagnostic imaging	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
gene expression regulation/genetics	receptors cxcr3/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
gene expression regulation/genetics	cd8-positive t-lymphocytes/cytology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
gene expression regulation/genetics	inflammation/drug therapy	7.89023857966642e-05	0.00022079679976021256	0.02127659574468085	0.8192464059779487	1	1
gene expression regulation/genetics	myeloid cells/cytology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
gene expression regulation/genetics	ctla-4 antigen/immunology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
gene expression regulation/genetics	colitis/drug therapy	0.00033215011278686646	0.0007621892351914595	0.031914893617021274	0.8192464059779487	1	1
gene expression regulation/genetics	receptors antigen t-cell/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
gene expression regulation/genetics	t-lymphocytes regulatory/cytology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
gene expression regulation/genetics	chemokines/metabolism	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
gene expression regulation/genetics	multigene family	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
gene expression regulation/genetics	melanoma/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
gene expression regulation/genetics	receptors cxcr6/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
receptors cxcr3/genetics	melanoma/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
receptors cxcr3/genetics	receptors cxcr6/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
receptors cxcr3/genetics	cd8-positive t-lymphocytes/cytology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
receptors cxcr3/genetics	inflammation/drug therapy	7.89023857966642e-05	0.00022079679976021256	0.02127659574468085	0.8192464059779487	1	1
receptors cxcr3/genetics	myeloid cells/cytology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
receptors cxcr3/genetics	ctla-4 antigen/immunology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
receptors cxcr3/genetics	colitis/drug therapy	0.00033215011278686646	0.0007621892351914595	0.031914893617021274	0.8192464059779487	1	1
receptors cxcr3/genetics	receptors antigen t-cell/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
receptors cxcr3/genetics	t-lymphocytes regulatory/cytology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
receptors cxcr3/genetics	chemokines/metabolism	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
receptors cxcr3/genetics	multigene family	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
cd8-positive t-lymphocytes/cytology	melanoma/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
cd8-positive t-lymphocytes/cytology	receptors cxcr6/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
cd8-positive t-lymphocytes/cytology	inflammation/drug therapy	7.89023857966642e-05	0.00022079679976021256	0.02127659574468085	0.8192464059779487	1	1
cd8-positive t-lymphocytes/cytology	myeloid cells/cytology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
cd8-positive t-lymphocytes/cytology	ctla-4 antigen/immunology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
cd8-positive t-lymphocytes/cytology	colitis/drug therapy	0.00033215011278686646	0.0007621892351914595	0.031914893617021274	0.8192464059779487	1	1
cd8-positive t-lymphocytes/cytology	receptors antigen t-cell/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
cd8-positive t-lymphocytes/cytology	t-lymphocytes regulatory/cytology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
cd8-positive t-lymphocytes/cytology	chemokines/metabolism	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
cd8-positive t-lymphocytes/cytology	multigene family	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
inflammation/drug therapy	melanoma/genetics	7.89023857966642e-05	0.00022079679976021256	0.02127659574468085	0.8192464059779487	1	1
inflammation/drug therapy	receptors cxcr6/genetics	7.89023857966642e-05	0.00022079679976021256	0.02127659574468085	0.8192464059779487	1	1
inflammation/drug therapy	myeloid cells/cytology	7.89023857966642e-05	0.00022079679976021256	0.02127659574468085	0.8192464059779487	1	1
inflammation/drug therapy	ctla-4 antigen/immunology	7.89023857966642e-05	0.00022079679976021256	0.02127659574468085	0.8192464059779487	1	1
inflammation/drug therapy	colitis/drug therapy	0.0020566383584686987	0.004003380010759681	0.06314344543582705	0.8192464059779487	1	1
inflammation/drug therapy	receptors antigen t-cell/genetics	7.89023857966642e-05	0.00022079679976021256	0.02127659574468085	0.8192464059779487	1	1
inflammation/drug therapy	t-lymphocytes regulatory/cytology	7.89023857966642e-05	0.00022079679976021256	0.02127659574468085	0.8192464059779487	1	1
inflammation/drug therapy	chemokines/metabolism	7.89023857966642e-05	0.00022079679976021256	0.02127659574468085	0.8192464059779487	1	1
inflammation/drug therapy	multigene family	7.89023857966642e-05	0.00022079679976021256	0.02127659574468085	0.8192464059779487	1	1
inflammation/drug therapy	beclomethasone/adverse effects	4.210187753983519e-12	5.3346478373455766e-11	0.02127659574468085	0.8192464059779487	1	1
myeloid cells/cytology	melanoma/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
myeloid cells/cytology	receptors cxcr6/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
myeloid cells/cytology	ctla-4 antigen/immunology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
myeloid cells/cytology	colitis/drug therapy	0.00033215011278686646	0.0007621892351914595	0.031914893617021274	0.8192464059779487	1	1
myeloid cells/cytology	receptors antigen t-cell/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
myeloid cells/cytology	t-lymphocytes regulatory/cytology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
myeloid cells/cytology	chemokines/metabolism	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
myeloid cells/cytology	multigene family	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
ctla-4 antigen/immunology	melanoma/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
ctla-4 antigen/immunology	receptors cxcr6/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
ctla-4 antigen/immunology	colitis/drug therapy	0.00033215011278686646	0.0007621892351914595	0.031914893617021274	0.8192464059779487	1	1
ctla-4 antigen/immunology	receptors antigen t-cell/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
ctla-4 antigen/immunology	t-lymphocytes regulatory/cytology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
ctla-4 antigen/immunology	chemokines/metabolism	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
ctla-4 antigen/immunology	multigene family	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
inflammatory bowel diseases	colitis/diagnosis	1.7539318886150568e-09	1.4086697058168173e-08	0.04232441088995653	0.8192464059779487	1	1
inflammatory bowel diseases	programmed cell death 1 receptor/metabolism	3.7636560534792807e-14	6.451981805964481e-13	0.02127659574468085	0.8192464059779487	1	1
inflammatory bowel diseases	immune checkpoint inhibitors/pharmacology	5.520278016424296e-05	0.00016451028899179036	0.08373369938229239	0.8192464059779487	1	1
inflammatory bowel diseases	gastrointestinal tract/metabolism	3.7636560534792807e-14	6.451981805964481e-13	0.02127659574468085	0.8192464059779487	1	1
inflammatory bowel diseases	b7-h1 antigen/metabolism	3.7636560534792807e-14	6.451981805964481e-13	0.02127659574468085	0.8192464059779487	1	1
hashimoto disease/chemically induced	squamous cell carcinoma of head and neck/drug therapy	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
hashimoto disease/chemically induced	tongue neoplasms/drug therapy	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
CHI3L1	CXCL8	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
CHI3L1	IL6	7.120456303022493e-06	2.9765841922471078e-05	0.02127659574468085	0.8192464059779487	1	1
colitis/drug therapy	melanoma/genetics	0.00033215011278686646	0.0007621892351914595	0.031914893617021274	0.8192464059779487	1	1
colitis/drug therapy	receptors cxcr6/genetics	0.00033215011278686646	0.0007621892351914595	0.031914893617021274	0.8192464059779487	1	1
colitis/drug therapy	diarrhea/therapy	3.3306690738754696e-16	7.900656872913904e-15	0.031914893617021274	0.8192464059779487	1	1
colitis/drug therapy	neoplasms/therapy	3.3306690738754696e-16	7.900656872913904e-15	0.031914893617021274	0.8192464059779487	1	1
colitis/drug therapy	receptors antigen t-cell/genetics	0.00033215011278686646	0.0007621892351914595	0.031914893617021274	0.8192464059779487	1	1
colitis/drug therapy	t-lymphocytes regulatory/cytology	0.00033215011278686646	0.0007621892351914595	0.031914893617021274	0.8192464059779487	1	1
colitis/drug therapy	feces/chemistry	8.497306969168505e-09	6.257944482708936e-08	0.031914893617021274	0.8192464059779487	1	1
colitis/drug therapy	leukocyte l1 antigen complex/analysis	8.497306969168505e-09	6.257944482708936e-08	0.031914893617021274	0.8192464059779487	1	1
colitis/drug therapy	chemokines/metabolism	0.00033215011278686646	0.0007621892351914595	0.031914893617021274	0.8192464059779487	1	1
colitis/drug therapy	multigene family	0.00033215011278686646	0.0007621892351914595	0.031914893617021274	0.8192464059779487	1	1
colitis/drug therapy	biomarkers/analysis	0.003406381472529474	0.0062887042569774905	0.06314344543582703	0.8192464059779487	1	1
intestinal mucosa/diagnostic imaging	colon/diagnostic imaging	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
intestinal mucosa/diagnostic imaging	drug resistance/immunology	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
intestinal mucosa/diagnostic imaging	skin neoplasms/drug therapy	2.7758322218573994e-07	1.8325882629738173e-06	0.02127659574468085	0.8192464059779487	1	1
intestinal mucosa/diagnostic imaging	infliximab/adverse effects	9.346086438544177e-06	3.8439549061754276e-05	0.0425531914893617	0.8192464059779487	1	1
intestinal mucosa/diagnostic imaging	glucocorticoids/pharmacology	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
intestinal mucosa/diagnostic imaging	immunosuppressive agents/pharmacology	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
intestinal mucosa/diagnostic imaging	mucositis/chemically induced	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
colon/diagnostic imaging	drug resistance/immunology	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
colon/diagnostic imaging	skin neoplasms/drug therapy	2.7758322218573994e-07	1.8325882629738173e-06	0.02127659574468085	0.8192464059779487	1	1
colon/diagnostic imaging	infliximab/adverse effects	9.346086438544177e-06	3.8439549061754276e-05	0.0425531914893617	0.8192464059779487	1	1
colon/diagnostic imaging	glucocorticoids/pharmacology	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
colon/diagnostic imaging	immunosuppressive agents/pharmacology	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
colon/diagnostic imaging	mucositis/chemically induced	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
drug resistance/immunology	skin neoplasms/drug therapy	2.7758322218573994e-07	1.8325882629738173e-06	0.02127659574468085	0.8192464059779487	1	1
drug resistance/immunology	infliximab/adverse effects	9.346086438544177e-06	3.8439549061754276e-05	0.0425531914893617	0.8192464059779487	1	1
drug resistance/immunology	glucocorticoids/pharmacology	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
drug resistance/immunology	immunosuppressive agents/pharmacology	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
drug resistance/immunology	mucositis/chemically induced	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
CXCL8	IL6	7.120456303022493e-06	2.9765841922471078e-05	0.02127659574468085	0.8192464059779487	1	1
IL6	immune system diseases/drug therapy	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL6	gastrointestinal neoplasms/drug therapy	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL6	BTLA	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL6	CD28	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL6	CSF2	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL6	HAVCR2	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL6	IL15	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL6	IL17C	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL6	IL21	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL6	IL22	0.005036248293187717	0.008972879055111741	0.04232441088995653	0.8192464059779487	1	1
IL6	IL4	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
IL6	LIF	0.0012804347551081952	0.002649175355396266	0.02127659574468085	0.8192464059779487	1	1
squamous cell carcinoma of head and neck/drug therapy	tongue neoplasms/drug therapy	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
receptors antigen t-cell/genetics	melanoma/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
receptors antigen t-cell/genetics	receptors cxcr6/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
receptors antigen t-cell/genetics	t-lymphocytes regulatory/cytology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
receptors antigen t-cell/genetics	chemokines/metabolism	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
receptors antigen t-cell/genetics	multigene family	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
myeloid-derived suppressor cells/metabolism	azoxymethane/adverse effects	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
myeloid-derived suppressor cells/metabolism	phthalazines/administration & dosage	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
myeloid-derived suppressor cells/metabolism	dextran sulfate/adverse effects	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
myeloid-derived suppressor cells/metabolism	colonic neoplasms/drug therapy	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
myeloid-derived suppressor cells/metabolism	cell line tumor	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
myeloid-derived suppressor cells/metabolism	poly(adp-ribose) polymerase inhibitors/administration & dosage	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
myeloid-derived suppressor cells/metabolism	piperazines/administration & dosage	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
myeloid-derived suppressor cells/metabolism	ARG1	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
myeloid-derived suppressor cells/metabolism	PARP1	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
myeloid-derived suppressor cells/metabolism	TIPARP	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
myeloid-derived suppressor cells/metabolism	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
azoxymethane/adverse effects	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
azoxymethane/adverse effects	colonic neoplasms/drug therapy	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
azoxymethane/adverse effects	cell line tumor	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
azoxymethane/adverse effects	poly(adp-ribose) polymerase inhibitors/administration & dosage	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
azoxymethane/adverse effects	piperazines/administration & dosage	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
azoxymethane/adverse effects	ARG1	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
azoxymethane/adverse effects	PARP1	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
azoxymethane/adverse effects	TIPARP	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
azoxymethane/adverse effects	phthalazines/administration & dosage	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
azoxymethane/adverse effects	dextran sulfate/adverse effects	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
skin neoplasms/drug therapy	infliximab/adverse effects	0.001115358873304495	0.002370137605772052	0.0837336993822924	0.8192464059779487	1	1
skin neoplasms/drug therapy	tumor necrosis factor inhibitors	8.497306969168505e-09	6.257944482708936e-08	0.02127659574468085	0.8192464059779487	1	1
skin neoplasms/drug therapy	glucocorticoids/pharmacology	2.7758322218573994e-07	1.8325882629738173e-06	0.02127659574468085	0.8192464059779487	1	1
skin neoplasms/drug therapy	immunosuppressive agents/pharmacology	2.7758322218573994e-07	1.8325882629738173e-06	0.02127659574468085	0.8192464059779487	1	1
skin neoplasms/drug therapy	mucositis/chemically induced	2.7758322218573994e-07	1.8325882629738173e-06	0.02127659574468085	0.8192464059779487	1	1
skin neoplasms/drug therapy	TNF	0.0008560312541340265	0.0018343526874300567	0.06314344543582705	0.8192464059779487	1	1
infliximab/adverse effects	antibodies monoclonal humanized/therapeutic use	1.4979129048242612e-12	2.425192322096423e-11	0.0425531914893617	0.8192464059779487	1	1
infliximab/adverse effects	steroids/adverse effects	1.4979129048242612e-12	2.425192322096423e-11	0.0425531914893617	0.8192464059779487	1	1
infliximab/adverse effects	glucocorticoids/pharmacology	9.346086438544177e-06	3.8439549061754276e-05	0.0425531914893617	0.8192464059779487	1	1
infliximab/adverse effects	immunosuppressive agents/pharmacology	9.346086438544177e-06	3.8439549061754276e-05	0.0425531914893617	0.8192464059779487	1	1
infliximab/adverse effects	drug-related side effects and adverse reactions	0.00010979661391830042	0.0003014604204486311	0.08373369938229239	0.8192464059779487	1	1
infliximab/adverse effects	mucositis/chemically induced	9.346086438544177e-06	3.8439549061754276e-05	0.0425531914893617	0.8192464059779487	1	1
infliximab/adverse effects	TNF	0.004247460502867173	0.007627481888951613	0.12357136462654053	0.8192464059779487	1	1
t-lymphocytes regulatory/cytology	melanoma/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
t-lymphocytes regulatory/cytology	receptors cxcr6/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
t-lymphocytes regulatory/cytology	chemokines/metabolism	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
t-lymphocytes regulatory/cytology	multigene family	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
sirolimus/therapeutic use	drug-related side effects and adverse reactions/prevention & control	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
sirolimus/therapeutic use	growth inhibitors/therapeutic use	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
sirolimus/therapeutic use	phosphatidylinositol 3-kinases/metabolism	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
sirolimus/therapeutic use	lymphocytes tumor-infiltrating/immunology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
sirolimus/therapeutic use	colitis/etiology	0.00017249631024596201	0.0004209240106480413	0.02127659574468085	0.8192464059779487	1	1
sirolimus/therapeutic use	cell line tumor	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
sirolimus/therapeutic use	cd8-positive t-lymphocytes/immunology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
sirolimus/therapeutic use	cytotoxicity immunologic	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
sirolimus/therapeutic use	MTOR	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
sirolimus/therapeutic use	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
drug-related side effects and adverse reactions/prevention & control	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
drug-related side effects and adverse reactions/prevention & control	growth inhibitors/therapeutic use	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
drug-related side effects and adverse reactions/prevention & control	phosphatidylinositol 3-kinases/metabolism	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
drug-related side effects and adverse reactions/prevention & control	lymphocytes tumor-infiltrating/immunology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
drug-related side effects and adverse reactions/prevention & control	colitis/etiology	0.00017249631024596201	0.0004209240106480413	0.02127659574468085	0.8192464059779487	1	1
drug-related side effects and adverse reactions/prevention & control	cell line tumor	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
drug-related side effects and adverse reactions/prevention & control	cd8-positive t-lymphocytes/immunology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
drug-related side effects and adverse reactions/prevention & control	cytotoxicity immunologic	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
drug-related side effects and adverse reactions/prevention & control	MTOR	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
immune checkpoint inhibitors/administration & dosage	urothelium/drug effects	0.0006000839098009303	0.0013378919956217462	0.0425531914893617	0.8192464059779487	1	1
immune checkpoint inhibitors/administration & dosage	neoplasms/diagnosis	0.0012632260982122778	0.002649175355396266	0.0425531914893617	0.8192464059779487	1	1
immune checkpoint inhibitors/administration & dosage	antibodies monoclonal humanized/administration & dosage	0.0012632260982122778	0.002649175355396266	0.0425531914893617	0.8192464059779487	1	1
immune checkpoint inhibitors/administration & dosage	carcinoma non-small-cell lung/complications	0.0006000839098009303	0.0013378919956217462	0.0425531914893617	0.8192464059779487	1	1
immune checkpoint inhibitors/administration & dosage	infliximab/administration & dosage	0.0006000839098009303	0.0013378919956217462	0.0425531914893617	0.8192464059779487	1	1
immune checkpoint inhibitors/administration & dosage	drugs investigational/administration & dosage	0.0012632260982122778	0.002649175355396266	0.0425531914893617	0.8192464059779487	1	1
immune checkpoint inhibitors/administration & dosage	CRP	0.0006000839098009303	0.0013378919956217462	0.0425531914893617	0.8192464059779487	1	1
phthalazines/administration & dosage	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
phthalazines/administration & dosage	dextran sulfate/adverse effects	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
phthalazines/administration & dosage	colonic neoplasms/drug therapy	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
phthalazines/administration & dosage	cell line tumor	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
phthalazines/administration & dosage	poly(adp-ribose) polymerase inhibitors/administration & dosage	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
phthalazines/administration & dosage	piperazines/administration & dosage	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
phthalazines/administration & dosage	ARG1	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
phthalazines/administration & dosage	PARP1	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
phthalazines/administration & dosage	TIPARP	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
dextran sulfate/adverse effects	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
dextran sulfate/adverse effects	cell line tumor	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
dextran sulfate/adverse effects	poly(adp-ribose) polymerase inhibitors/administration & dosage	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
dextran sulfate/adverse effects	piperazines/administration & dosage	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
dextran sulfate/adverse effects	ARG1	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
dextran sulfate/adverse effects	PARP1	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
dextran sulfate/adverse effects	TIPARP	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
dextran sulfate/adverse effects	colonic neoplasms/drug therapy	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
carcinoma renal cell/drug therapy	inflammatory bowel diseases/drug therapy	0.0008560312541340265	0.0018343526874300567	0.06314344543582705	0.8192464059779487	1	1
carcinoma renal cell/drug therapy	proton pump inhibitors/adverse effects	1.0760137225673816e-10	1.233184266313179e-09	0.02127659574468085	0.8192464059779487	1	1
chemokines/metabolism	melanoma/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
chemokines/metabolism	receptors cxcr6/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
chemokines/metabolism	multigene family	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
multigene family	melanoma/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
multigene family	receptors cxcr6/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
colonic neoplasms/drug therapy	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
colonic neoplasms/drug therapy	cell line tumor	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
colonic neoplasms/drug therapy	poly(adp-ribose) polymerase inhibitors/administration & dosage	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
colonic neoplasms/drug therapy	piperazines/administration & dosage	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
colonic neoplasms/drug therapy	ARG1	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
colonic neoplasms/drug therapy	PARP1	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
colonic neoplasms/drug therapy	TIPARP	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
glucocorticoids/pharmacology	immunosuppressive agents/pharmacology	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
glucocorticoids/pharmacology	mucositis/chemically induced	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
cell line tumor	drug synergism	1.2231703854337361e-05	4.9607705492739994e-05	0.00022878059940517045	0.5658111483402343	2	1
cell line tumor	growth inhibitors/therapeutic use	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
cell line tumor	phosphatidylinositol 3-kinases/metabolism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
cell line tumor	lymphocytes tumor-infiltrating/immunology	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
cell line tumor	poly(adp-ribose) polymerase inhibitors/administration & dosage	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
cell line tumor	cd8-positive t-lymphocytes/immunology	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
cell line tumor	piperazines/administration & dosage	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
cell line tumor	cytotoxicity immunologic	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
cell line tumor	ARG1	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
cell line tumor	MTOR	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
cell line tumor	PARP1	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
cell line tumor	TIPARP	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
poly(adp-ribose) polymerase inhibitors/administration & dosage	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
poly(adp-ribose) polymerase inhibitors/administration & dosage	piperazines/administration & dosage	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
poly(adp-ribose) polymerase inhibitors/administration & dosage	ARG1	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
poly(adp-ribose) polymerase inhibitors/administration & dosage	PARP1	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
poly(adp-ribose) polymerase inhibitors/administration & dosage	TIPARP	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
immunosuppressive agents/pharmacology	mucositis/chemically induced	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
growth inhibitors/therapeutic use	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
growth inhibitors/therapeutic use	phosphatidylinositol 3-kinases/metabolism	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
growth inhibitors/therapeutic use	lymphocytes tumor-infiltrating/immunology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
growth inhibitors/therapeutic use	colitis/etiology	0.00017249631024596201	0.0004209240106480413	0.02127659574468085	0.8192464059779487	1	1
growth inhibitors/therapeutic use	cd8-positive t-lymphocytes/immunology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
growth inhibitors/therapeutic use	cytotoxicity immunologic	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
growth inhibitors/therapeutic use	MTOR	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
piperazines/administration & dosage	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
piperazines/administration & dosage	ARG1	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
piperazines/administration & dosage	PARP1	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
piperazines/administration & dosage	TIPARP	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
ARG1	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
ARG1	PARP1	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
ARG1	TIPARP	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
phosphatidylinositol 3-kinases/metabolism	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
phosphatidylinositol 3-kinases/metabolism	lymphocytes tumor-infiltrating/immunology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
phosphatidylinositol 3-kinases/metabolism	colitis/etiology	0.00017249631024596201	0.0004209240106480413	0.02127659574468085	0.8192464059779487	1	1
phosphatidylinositol 3-kinases/metabolism	cd8-positive t-lymphocytes/immunology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
phosphatidylinositol 3-kinases/metabolism	cytotoxicity immunologic	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
phosphatidylinositol 3-kinases/metabolism	MTOR	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
inflammatory bowel diseases/drug therapy	proton pump inhibitors/adverse effects	2.680078381445128e-13	4.5561332484567174e-12	0.031914893617021274	0.8192464059779487	1	1
inflammatory bowel diseases/drug therapy	CD4	0.00014918924112905518	0.00036756769553535334	0.06314344543582703	0.8192464059779487	1	1
inflammatory bowel diseases/drug therapy	CD68	0.00014918924112905518	0.00036756769553535334	0.06314344543582703	0.8192464059779487	1	1
antineoplastic agents immunological/therapeutic use	glucocorticoids/therapeutic use	0.00039622297225094805	0.0009041329568142439	0.031914893617021274	0.8192464059779487	1	1
antineoplastic agents immunological/therapeutic use	disease progression	0.00039622297225094805	0.0009041329568142439	0.031914893617021274	0.8192464059779487	1	1
antineoplastic agents immunological/therapeutic use	abdominal pain/chemically induced	0.00039622297225094805	0.0009041329568142439	0.031914893617021274	0.8192464059779487	1	1
antineoplastic agents immunological/therapeutic use	gastritis/complications	0.00039622297225094805	0.0009041329568142439	0.031914893617021274	0.8192464059779487	1	1
antineoplastic agents immunological/therapeutic use	enterocolitis/chemically induced	0.002353890853270424	0.004504631651661974	0.06314344543582703	0.8192464059779487	1	1
lymphocytes tumor-infiltrating/immunology	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
lymphocytes tumor-infiltrating/immunology	colitis/etiology	0.00017249631024596201	0.0004209240106480413	0.02127659574468085	0.8192464059779487	1	1
lymphocytes tumor-infiltrating/immunology	cd8-positive t-lymphocytes/immunology	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
lymphocytes tumor-infiltrating/immunology	cytotoxicity immunologic	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
lymphocytes tumor-infiltrating/immunology	MTOR	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
colitis/etiology	host microbial interactions/drug effects	2.6289789900602045e-08	1.8950943956617727e-07	0.02127659574468085	0.8192464059779487	1	1
colitis/etiology	metabolome/drug effects	2.6289789900602045e-08	1.8950943956617727e-07	0.02127659574468085	0.8192464059779487	1	1
colitis/etiology	dysbiosis/etiology	2.6289789900602045e-08	1.8950943956617727e-07	0.02127659574468085	0.8192464059779487	1	1
colitis/etiology	neoplasms/complications	0.0009096066042627582	0.0019349295857101427	0.06314344543582703	0.8192464059779487	1	1
colitis/etiology	cd8-positive t-lymphocytes/immunology	0.00017249631024596201	0.0004209240106480413	0.02127659574468085	0.8192464059779487	1	1
colitis/etiology	anti-bacterial agents/pharmacology	2.6289789900602045e-08	1.8950943956617727e-07	0.02127659574468085	0.8192464059779487	1	1
colitis/etiology	cytotoxicity immunologic	0.00017249631024596201	0.0004209240106480413	0.02127659574468085	0.8192464059779487	1	1
colitis/etiology	MTOR	0.00017249631024596201	0.0004209240106480413	0.02127659574468085	0.8192464059779487	1	1
PARP1	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
PARP1	TIPARP	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
TIPARP	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
ulcer/chemically induced	esophagitis	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
cd8-positive t-lymphocytes/immunology	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
cd8-positive t-lymphocytes/immunology	cytotoxicity immunologic	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
cd8-positive t-lymphocytes/immunology	MTOR	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
cytotoxicity immunologic	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
cytotoxicity immunologic	MTOR	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
psoriasis	dermatitis	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
psoriasis	rna	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
psoriasis	CXCL10	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
psoriasis	CXCL9	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
psoriasis	TCIM	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
psoriasis	TNF	5.894001962603035e-06	2.5049508341062898e-05	0.031914893617021274	0.8192464059779487	1	1
melanoma/genetics	receptors cxcr6/genetics	4.610742208699392e-06	2.0359121441010303e-05	0.010638297872340427	0.8192464059779487	1	1
MTOR	drug synergism	0.0014238434237268116	0.0028393358596311784	0.02127659574468085	0.8192464059779487	1	1
colitis ulcerative/immunology	pyrimidines/therapeutic use	0.001617782544867441	0.003197942239854244	0.04232441088995653	0.8192464059779487	1	1
colitis ulcerative/immunology	macrophages/drug effects	5.894001962603035e-06	2.5049508341062898e-05	0.02127659574468085	0.8192464059779487	1	1
colitis ulcerative/immunology	interferon-gamma/metabolism	7.667010243472827e-05	0.00021783705984240343	0.02127659574468085	0.8192464059779487	1	1
colitis ulcerative/immunology	immunologic memory/drug effects	7.667010243472827e-05	0.00021783705984240343	0.02127659574468085	0.8192464059779487	1	1
colitis ulcerative/immunology	colon/drug effects	6.451230186721446e-07	4.138525025443947e-06	0.0006863417982155114	0.5658111483402343	2	1
colitis ulcerative/immunology	crohn disease/immunology	5.894001962603035e-06	2.5049508341062898e-05	0.02127659574468085	0.8192464059779487	1	1
colitis ulcerative/immunology	graft vs host disease/immunology	5.894001962603035e-06	2.5049508341062898e-05	0.02127659574468085	0.8192464059779487	1	1
colitis ulcerative/immunology	cd8-positive t-lymphocytes/drug effects	4.87079765409959e-09	3.807060235388186e-08	0.00022878059940517045	0.5658111483402343	2	1
colitis ulcerative/immunology	phenotype	4.87079765409959e-09	3.807060235388186e-08	0.00022878059940517045	0.5658111483402343	2	1
colitis ulcerative/immunology	CD4	0.0008560312541340265	0.0018343526874300567	0.04232441088995653	0.8192464059779487	1	1
colitis ulcerative/immunology	CD68	0.0008560312541340265	0.0018343526874300567	0.04232441088995653	0.8192464059779487	1	1
pyrimidines/therapeutic use	interferon-gamma/metabolism	2.117447749905299e-05	7.4092511317441e-05	0.02127659574468085	0.8192464059779487	1	1
pyrimidines/therapeutic use	immunologic memory/drug effects	2.117447749905299e-05	7.4092511317441e-05	0.02127659574468085	0.8192464059779487	1	1
pyrimidines/therapeutic use	protein kinase inhibitors/therapeutic use	5.172982153744954e-09	3.997304391530191e-08	0.02127659574468085	0.8192464059779487	1	1
pyrimidines/therapeutic use	cd8-positive t-lymphocytes/drug effects	0.001617782544867441	0.003197942239854244	0.04232441088995653	0.8192464059779487	1	1
pyrimidines/therapeutic use	phenotype	0.001617782544867441	0.003197942239854244	0.04232441088995653	0.8192464059779487	1	1
dermatitis	rna	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
dermatitis	CXCL10	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
dermatitis	CXCL9	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
dermatitis	TCIM	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
dermatitis	TNF	5.894001962603035e-06	2.5049508341062898e-05	0.031914893617021274	0.8192464059779487	1	1
macrophages/drug effects	colon/drug effects	0.00010409344358552897	0.0002861868260302953	0.031914893617021274	0.8192464059779487	1	1
macrophages/drug effects	crohn disease/immunology	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
macrophages/drug effects	graft vs host disease/immunology	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
macrophages/drug effects	cd8-positive t-lymphocytes/drug effects	5.894001962603035e-06	2.5049508341062898e-05	0.02127659574468085	0.8192464059779487	1	1
macrophages/drug effects	phenotype	5.894001962603035e-06	2.5049508341062898e-05	0.02127659574468085	0.8192464059779487	1	1
macrophages/drug effects	CD4	2.7758322218573994e-07	1.8325882629738173e-06	0.02127659574468085	0.8192464059779487	1	1
macrophages/drug effects	CD68	2.7758322218573994e-07	1.8325882629738173e-06	0.02127659574468085	0.8192464059779487	1	1
interferon-gamma/metabolism	immunologic memory/drug effects	1.1173021974286712e-07	7.914223898453088e-07	0.010638297872340427	0.8192464059779487	1	1
interferon-gamma/metabolism	colon/drug effects	0.0007200871327536218	0.0015880840549377172	0.031914893617021274	0.8192464059779487	1	1
interferon-gamma/metabolism	ctla-4 antigen/antagonists & inhibitors	0.000882536720319127	0.0018871854396761206	0.031914893617021274	0.8192464059779487	1	1
interferon-gamma/metabolism	cd8-positive t-lymphocytes/drug effects	7.667010243472827e-05	0.00021783705984240343	0.02127659574468085	0.8192464059779487	1	1
interferon-gamma/metabolism	phenotype	7.667010243472827e-05	0.00021783705984240343	0.02127659574468085	0.8192464059779487	1	1
immunologic memory/drug effects	colon/drug effects	0.0007200871327536218	0.0015880840549377172	0.031914893617021274	0.8192464059779487	1	1
immunologic memory/drug effects	ctla-4 antigen/antagonists & inhibitors	0.000882536720319127	0.0018871854396761206	0.031914893617021274	0.8192464059779487	1	1
immunologic memory/drug effects	cd8-positive t-lymphocytes/drug effects	7.667010243472827e-05	0.00021783705984240343	0.02127659574468085	0.8192464059779487	1	1
immunologic memory/drug effects	phenotype	7.667010243472827e-05	0.00021783705984240343	0.02127659574468085	0.8192464059779487	1	1
colon/drug effects	protective agents/pharmacology	1.316505098991616e-05	5.2971802799662655e-05	0.031914893617021274	0.8192464059779487	1	1
colon/drug effects	mesalamine/pharmacology	1.316505098991616e-05	5.2971802799662655e-05	0.031914893617021274	0.8192464059779487	1	1
colon/drug effects	crohn disease/immunology	0.00010409344358552897	0.0002861868260302953	0.031914893617021274	0.8192464059779487	1	1
colon/drug effects	trinitrobenzenesulfonic acid/adverse effects	1.316505098991616e-05	5.2971802799662655e-05	0.031914893617021274	0.8192464059779487	1	1
colon/drug effects	graft vs host disease/immunology	0.00010409344358552897	0.0002861868260302953	0.031914893617021274	0.8192464059779487	1	1
colon/drug effects	cd8-positive t-lymphocytes/drug effects	6.451230186721446e-07	4.138525025443947e-06	0.0006863417982155113	0.5658111483402343	2	1
colon/drug effects	phenotype	6.451230186721446e-07	4.138525025443947e-06	0.0006863417982155113	0.5658111483402343	2	1
colon/drug effects	ACAD8	0.0024588010400659055	0.004648706322274742	0.06314344543582703	0.8192464059779487	1	1
colon/drug effects	CD4	0.00447563644916571	0.008023109276184576	0.06314344543582703	0.8192464059779487	1	1
colon/drug effects	CD68	0.00447563644916571	0.008023109276184576	0.06314344543582703	0.8192464059779487	1	1
prednisolone/therapeutic use	lung neoplasms/drug therapy	0.0	0.0	0.02127659574468085	0.8192464059779487	1	1
rna	CXCL10	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
rna	CXCL9	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
rna	TCIM	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
rna	TNF	5.894001962603035e-06	2.5049508341062898e-05	0.031914893617021274	0.8192464059779487	1	1
crohn disease/immunology	graft vs host disease/immunology	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
crohn disease/immunology	cd8-positive t-lymphocytes/drug effects	5.894001962603035e-06	2.5049508341062898e-05	0.02127659574468085	0.8192464059779487	1	1
crohn disease/immunology	phenotype	5.894001962603035e-06	2.5049508341062898e-05	0.02127659574468085	0.8192464059779487	1	1
crohn disease/immunology	CD4	2.7758322218573994e-07	1.8325882629738173e-06	0.02127659574468085	0.8192464059779487	1	1
crohn disease/immunology	CD68	2.7758322218573994e-07	1.8325882629738173e-06	0.02127659574468085	0.8192464059779487	1	1
CXCL10	CXCL9	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
CXCL10	TCIM	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
CXCL10	TNF	5.894001962603035e-06	2.5049508341062898e-05	0.031914893617021274	0.8192464059779487	1	1
CXCL9	TCIM	4.210187753983519e-12	5.3346478373455766e-11	0.010638297872340427	0.8192464059779487	1	1
CXCL9	TNF	5.894001962603035e-06	2.5049508341062898e-05	0.031914893617021274	0.8192464059779487	1	1
TCIM	TNF	5.894001962603035e-06	2.5049508341062898e-05	0.031914893617021274	0.8192464059779487	1	1
TNF	tumor necrosis factor inhibitors	3.7634103677852693e-07	2.4450182007267355e-06	0.031914893617021274	0.8192464059779487	1	1
TNF	drug-related side effects and adverse reactions	7.667010243472827e-05	0.00021783705984240343	0.06314344543582705	0.8192464059779487	1	1
ctla-4 antigen/antagonists & inhibitors	lymphocytes/drug effects	0.0002818746185764276	0.0006571705393096141	0.031914893617021274	0.8192464059779487	1	1
ctla-4 antigen/antagonists & inhibitors	vitamin d/administration & dosage	0.0002818746185764276	0.0006571705393096141	0.031914893617021274	0.8192464059779487	1	1
ctla-4 antigen/antagonists & inhibitors	neutrophils/drug effects	0.0002818746185764276	0.0006571705393096141	0.031914893617021274	0.8192464059779487	1	1
ctla-4 antigen/antagonists & inhibitors	antibodies monoclonal/adverse effects	0.0002818746185764276	0.0006571705393096141	0.031914893617021274	0.8192464059779487	1	1
graft vs host disease/immunology	cd8-positive t-lymphocytes/drug effects	5.894001962603035e-06	2.5049508341062898e-05	0.02127659574468085	0.8192464059779487	1	1
graft vs host disease/immunology	phenotype	5.894001962603035e-06	2.5049508341062898e-05	0.02127659574468085	0.8192464059779487	1	1
graft vs host disease/immunology	CD4	2.7758322218573994e-07	1.8325882629738173e-06	0.02127659574468085	0.8192464059779487	1	1
graft vs host disease/immunology	CD68	2.7758322218573994e-07	1.8325882629738173e-06	0.02127659574468085	0.8192464059779487	1	1
cd8-positive t-lymphocytes/drug effects	phenotype	4.87079765409959e-09	3.807060235388186e-08	0.00022878059940517045	0.5658111483402343	2	1
cd8-positive t-lymphocytes/drug effects	CD4	0.0008560312541340265	0.0018343526874300567	0.04232441088995653	0.8192464059779487	1	1
cd8-positive t-lymphocytes/drug effects	CD68	0.0008560312541340265	0.0018343526874300567	0.04232441088995653	0.8192464059779487	1	1
phenotype	CD4	0.0008560312541340265	0.0018343526874300567	0.04232441088995653	0.8192464059779487	1	1
phenotype	CD68	0.0008560312541340265	0.0018343526874300567	0.04232441088995653	0.8192464059779487	1	1
CD4	CD68	3.4083846855992306e-14	6.046178050976027e-13	0.00022878059940517045	0.5658111483402343	2	1
host microbial interactions/drug effects	metabolome/drug effects	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
host microbial interactions/drug effects	dysbiosis/etiology	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
host microbial interactions/drug effects	neoplasms/complications	2.0219889096395605e-09	1.5987819285522107e-08	0.031914893617021274	0.8192464059779487	1	1
host microbial interactions/drug effects	anti-bacterial agents/pharmacology	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
metabolome/drug effects	dysbiosis/etiology	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
metabolome/drug effects	neoplasms/complications	2.0219889096395605e-09	1.5987819285522107e-08	0.031914893617021274	0.8192464059779487	1	1
metabolome/drug effects	anti-bacterial agents/pharmacology	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
dysbiosis/etiology	neoplasms/complications	2.0219889096395605e-09	1.5987819285522107e-08	0.031914893617021274	0.8192464059779487	1	1
dysbiosis/etiology	anti-bacterial agents/pharmacology	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
neoplasms/complications	colitis/epidemiology	8.899991854605105e-11	1.0257617730731307e-09	0.031914893617021274	0.8192464059779487	1	1
neoplasms/complications	inflammatory bowel diseases/complications	1.3296867273915325e-07	9.321515202332394e-07	0.06314344543582703	0.8192464059779487	1	1
neoplasms/complications	anti-bacterial agents/pharmacology	2.0219889096395605e-09	1.5987819285522107e-08	0.031914893617021274	0.8192464059779487	1	1
neoplasms/complications	b7-h1 antigen/antagonists & inhibitors	0.00048617385995042284	0.0010922848835890559	0.09369311569335442	0.8192464059779487	1	1
urothelium/drug effects	carcinoma non-small-cell lung/complications	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
urothelium/drug effects	drug-related side effects and adverse reactions	1.0937584171699655e-11	1.3522831339555936e-10	0.02127659574468085	0.8192464059779487	1	1
urothelium/drug effects	melanoma/complications	3.7634103677852693e-07	2.4450182007267355e-06	0.031914893617021274	0.8192464059779487	1	1
urothelium/drug effects	infliximab/administration & dosage	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
urothelium/drug effects	ACAD8	9.71451141751345e-10	7.927041316690975e-09	0.02127659574468085	0.8192464059779487	1	1
urothelium/drug effects	CRP	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
protective agents/pharmacology	mesalamine/pharmacology	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
protective agents/pharmacology	immune checkpoint inhibitors/pharmacology	6.663603689949227e-07	4.234813559967733e-06	0.0425531914893617	0.8192464059779487	1	1
protective agents/pharmacology	trinitrobenzenesulfonic acid/adverse effects	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
protective agents/pharmacology	ACAD8	9.71451141751345e-10	7.927041316690975e-09	0.02127659574468085	0.8192464059779487	1	1
mesalamine/pharmacology	immune checkpoint inhibitors/pharmacology	6.663603689949227e-07	4.234813559967733e-06	0.0425531914893617	0.8192464059779487	1	1
mesalamine/pharmacology	trinitrobenzenesulfonic acid/adverse effects	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
mesalamine/pharmacology	ACAD8	9.71451141751345e-10	7.927041316690975e-09	0.02127659574468085	0.8192464059779487	1	1
carcinoma non-small-cell lung/complications	drug-related side effects and adverse reactions	1.0937584171699655e-11	1.3522831339555936e-10	0.02127659574468085	0.8192464059779487	1	1
carcinoma non-small-cell lung/complications	melanoma/complications	3.7634103677852693e-07	2.4450182007267355e-06	0.031914893617021274	0.8192464059779487	1	1
carcinoma non-small-cell lung/complications	infliximab/administration & dosage	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
carcinoma non-small-cell lung/complications	ACAD8	9.71451141751345e-10	7.927041316690975e-09	0.02127659574468085	0.8192464059779487	1	1
carcinoma non-small-cell lung/complications	CRP	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
drug-related side effects and adverse reactions	melanoma/complications	7.667010243472827e-05	0.00021783705984240343	0.06314344543582705	0.8192464059779487	1	1
drug-related side effects and adverse reactions	infliximab/administration & dosage	1.0937584171699655e-11	1.3522831339555936e-10	0.02127659574468085	0.8192464059779487	1	1
drug-related side effects and adverse reactions	ACAD8	1.8351282284889692e-06	1.1413602396699686e-05	0.04232441088995653	0.8192464059779487	1	1
drug-related side effects and adverse reactions	CRP	1.0937584171699655e-11	1.3522831339555936e-10	0.02127659574468085	0.8192464059779487	1	1
melanoma/complications	skin neoplasms/complications	4.874989301129062e-13	8.151621454346956e-12	0.031914893617021274	0.8192464059779487	1	1
melanoma/complications	colitis collagenous/drug therapy	4.874989301129062e-13	8.151621454346956e-12	0.031914893617021274	0.8192464059779487	1	1
melanoma/complications	lymphocytes/drug effects	1.6134051438077002e-05	6.398358813718091e-05	0.031914893617021274	0.8192464059779487	1	1
melanoma/complications	vitamin d/administration & dosage	1.6134051438077002e-05	6.398358813718091e-05	0.031914893617021274	0.8192464059779487	1	1
melanoma/complications	immune checkpoint inhibitors/pharmacology	0.004247460502867173	0.007627481888951613	0.12357136462654053	0.8192464059779487	1	1
melanoma/complications	infliximab/administration & dosage	3.7634103677852693e-07	2.4450182007267355e-06	0.031914893617021274	0.8192464059779487	1	1
melanoma/complications	ACAD8	0.00038869347608039284	0.0008909378552853948	0.06314344543582703	0.8192464059779487	1	1
melanoma/complications	CRP	3.7634103677852693e-07	2.4450182007267355e-06	0.031914893617021274	0.8192464059779487	1	1
melanoma/complications	neutrophils/drug effects	1.6134051438077002e-05	6.398358813718091e-05	0.031914893617021274	0.8192464059779487	1	1
melanoma/complications	antibodies monoclonal/adverse effects	1.6134051438077002e-05	6.398358813718091e-05	0.031914893617021274	0.8192464059779487	1	1
carcinoma non-small-cell lung	cd8-positive t-lymphocytes	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
infliximab/administration & dosage	ACAD8	9.71451141751345e-10	7.927041316690975e-09	0.02127659574468085	0.8192464059779487	1	1
infliximab/administration & dosage	CRP	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
immune checkpoint inhibitors/pharmacology	skin neoplasms/complications	1.4979129048242612e-12	2.425192322096423e-11	0.0425531914893617	0.8192464059779487	1	1
immune checkpoint inhibitors/pharmacology	tryptophan/pharmacology	2.652003061598407e-10	2.6985880197116785e-09	0.0425531914893617	0.8192464059779487	1	1
immune checkpoint inhibitors/pharmacology	colitis/diagnosis	2.4577273372017316e-05	8.570536355370142e-05	0.0837336993822924	0.8192464059779487	1	1
immune checkpoint inhibitors/pharmacology	programmed cell death 1 receptor/metabolism	1.0226270596991327e-07	7.268847392983382e-07	0.0425531914893617	0.8192464059779487	1	1
immune checkpoint inhibitors/pharmacology	colitis collagenous/drug therapy	1.4979129048242612e-12	2.425192322096423e-11	0.0425531914893617	0.8192464059779487	1	1
immune checkpoint inhibitors/pharmacology	trinitrobenzenesulfonic acid/adverse effects	6.663603689949227e-07	4.234813559967733e-06	0.0425531914893617	0.8192464059779487	1	1
immune checkpoint inhibitors/pharmacology	gastrointestinal tract/metabolism	1.0226270596991327e-07	7.268847392983382e-07	0.0425531914893617	0.8192464059779487	1	1
immune checkpoint inhibitors/pharmacology	b7-h1 antigen/metabolism	1.0226270596991327e-07	7.268847392983382e-07	0.0425531914893617	0.8192464059779487	1	1
immune checkpoint inhibitors/pharmacology	ACAD8	0.000522250836620497	0.0011720480821846137	0.08373369938229239	0.8192464059779487	1	1
immune checkpoint inhibitors/pharmacology	AHR	2.652003061598407e-10	2.6985880197116785e-09	0.0425531914893617	0.8192464059779487	1	1
immune checkpoint inhibitors/pharmacology	IL22	0.003406381472529474	0.0062887042569774905	0.08373369938229239	0.8192464059779487	1	1
ACAD8	CRP	9.71451141751345e-10	7.927041316690975e-09	0.02127659574468085	0.8192464059779487	1	1
ACAD8	trinitrobenzenesulfonic acid/adverse effects	9.71451141751345e-10	7.927041316690975e-09	0.02127659574468085	0.8192464059779487	1	1
adrenal cortex hormones/therapeutic use	tumor necrosis factor inhibitors	3.2688659694746214e-05	0.00011360283778071939	0.0425531914893617	0.8192464059779487	1	1
adrenal cortex hormones/therapeutic use	biological products/therapeutic use	1.2194914156271608e-07	8.5784913375152e-07	0.0425531914893617	0.8192464059779487	1	1
adrenal cortex hormones/therapeutic use	beclomethasone/adverse effects	1.2194914156271608e-07	8.5784913375152e-07	0.0425531914893617	0.8192464059779487	1	1
adrenal cortex hormones/therapeutic use	antineoplastic agents/adverse effects	0.003954425372989068	0.007113781094266048	0.0425531914893617	0.8192464059779487	1	1
adrenal cortex hormones/therapeutic use	intestinal mucosa/chemistry	0.003954425372989068	0.007113781094266048	0.0425531914893617	0.8192464059779487	1	1
adrenal cortex hormones/therapeutic use	leukemia lymphocytic chronic b-cell/drug therapy	0.003954425372989068	0.007113781094266048	0.0425531914893617	0.8192464059779487	1	1
adrenal cortex hormones/therapeutic use	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.003954425372989068	0.007113781094266048	0.0425531914893617	0.8192464059779487	1	1
adrenal cortex hormones/therapeutic use	purines/adverse effects	0.003954425372989068	0.007113781094266048	0.0425531914893617	0.8192464059779487	1	1
adrenal cortex hormones/therapeutic use	colon/chemistry	0.003954425372989068	0.007113781094266048	0.0425531914893617	0.8192464059779487	1	1
adrenal cortex hormones/therapeutic use	lymphocytosis/chemically induced	0.003954425372989068	0.007113781094266048	0.0425531914893617	0.8192464059779487	1	1
adrenal cortex hormones/therapeutic use	protein kinase inhibitors/adverse effects	0.003954425372989068	0.007113781094266048	0.0425531914893617	0.8192464059779487	1	1
adrenal cortex hormones/therapeutic use	apoptosis/drug effects	0.003954425372989068	0.007113781094266048	0.0425531914893617	0.8192464059779487	1	1
adrenal cortex hormones/therapeutic use	quinazolinones/adverse effects	0.003954425372989068	0.007113781094266048	0.0425531914893617	0.8192464059779487	1	1
adrenal cortex hormones/therapeutic use	lymphoma non-hodgkin/drug therapy	0.003954425372989068	0.007113781094266048	0.0425531914893617	0.8192464059779487	1	1
adrenal cortex hormones/therapeutic use	PIK3CD	0.003954425372989068	0.007113781094266048	0.0425531914893617	0.8192464059779487	1	1
pneumonia	ligands	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
immune system diseases/drug therapy	gastrointestinal neoplasms/drug therapy	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
immune system diseases/drug therapy	BTLA	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
immune system diseases/drug therapy	CD28	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
immune system diseases/drug therapy	CSF2	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
immune system diseases/drug therapy	HAVCR2	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
immune system diseases/drug therapy	IL15	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
immune system diseases/drug therapy	IL17C	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
immune system diseases/drug therapy	IL21	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
immune system diseases/drug therapy	IL22	0.0004354659220840995	0.0009805192947588996	0.02127659574468085	0.8192464059779487	1	1
immune system diseases/drug therapy	IL4	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
immune system diseases/drug therapy	LIF	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
glucocorticoids/therapeutic use	disease progression	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
glucocorticoids/therapeutic use	abdominal pain/chemically induced	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
glucocorticoids/therapeutic use	gastritis/complications	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
glucocorticoids/therapeutic use	enterocolitis/chemically induced	2.649280794742026e-11	3.1421702449265886e-10	0.02127659574468085	0.8192464059779487	1	1
micrornas/genetics	gene expression regulation neoplastic	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
micrornas/genetics	lymphocytes tumor-infiltrating/metabolism	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
micrornas/genetics	t-lymphocytes cytotoxic/immunology	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
micrornas/genetics	tumor microenvironment/drug effects	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
micrornas/genetics	ht29 cells	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
micrornas/genetics	colorectal neoplasms/drug therapy	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
micrornas/genetics	b7-h1 antigen/genetics	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
disease progression	abdominal pain/chemically induced	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
disease progression	gastritis/complications	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
disease progression	enterocolitis/chemically induced	2.649280794742026e-11	3.1421702449265886e-10	0.02127659574468085	0.8192464059779487	1	1
gene expression regulation neoplastic	lymphocytes tumor-infiltrating/metabolism	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
gene expression regulation neoplastic	t-lymphocytes cytotoxic/immunology	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
gene expression regulation neoplastic	tumor microenvironment/drug effects	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
gene expression regulation neoplastic	ht29 cells	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
gene expression regulation neoplastic	colorectal neoplasms/drug therapy	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
gene expression regulation neoplastic	b7-h1 antigen/genetics	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
lymphocytes tumor-infiltrating/metabolism	t-lymphocytes cytotoxic/immunology	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
lymphocytes tumor-infiltrating/metabolism	tumor microenvironment/drug effects	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
lymphocytes tumor-infiltrating/metabolism	ht29 cells	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
lymphocytes tumor-infiltrating/metabolism	colorectal neoplasms/drug therapy	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
lymphocytes tumor-infiltrating/metabolism	b7-h1 antigen/genetics	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
t-lymphocytes cytotoxic/immunology	tumor microenvironment/drug effects	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
t-lymphocytes cytotoxic/immunology	ht29 cells	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
t-lymphocytes cytotoxic/immunology	colorectal neoplasms/drug therapy	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
t-lymphocytes cytotoxic/immunology	b7-h1 antigen/genetics	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
tumor microenvironment/drug effects	ht29 cells	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
tumor microenvironment/drug effects	colorectal neoplasms/drug therapy	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
tumor microenvironment/drug effects	b7-h1 antigen/genetics	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
biomarkers/analysis	leukocyte l1 antigen complex/analysis	1.7539318886150568e-09	1.4086697058168173e-08	0.02127659574468085	0.8192464059779487	1	1
biomarkers/analysis	feces/chemistry	1.7539318886150568e-09	1.4086697058168173e-08	0.02127659574468085	0.8192464059779487	1	1
biomarkers/analysis	antineoplastic agents/adverse effects	0.0002818746185764276	0.0006571705393096141	0.02127659574468085	0.8192464059779487	1	1
biomarkers/analysis	intestinal mucosa/chemistry	0.0002818746185764276	0.0006571705393096141	0.02127659574468085	0.8192464059779487	1	1
biomarkers/analysis	leukemia lymphocytic chronic b-cell/drug therapy	0.0002818746185764276	0.0006571705393096141	0.02127659574468085	0.8192464059779487	1	1
biomarkers/analysis	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	0.0002818746185764276	0.0006571705393096141	0.02127659574468085	0.8192464059779487	1	1
biomarkers/analysis	purines/adverse effects	0.0002818746185764276	0.0006571705393096141	0.02127659574468085	0.8192464059779487	1	1
biomarkers/analysis	colon/chemistry	0.0002818746185764276	0.0006571705393096141	0.02127659574468085	0.8192464059779487	1	1
biomarkers/analysis	lymphocytosis/chemically induced	0.0002818746185764276	0.0006571705393096141	0.02127659574468085	0.8192464059779487	1	1
biomarkers/analysis	protein kinase inhibitors/adverse effects	0.0002818746185764276	0.0006571705393096141	0.02127659574468085	0.8192464059779487	1	1
biomarkers/analysis	apoptosis/drug effects	0.0002818746185764276	0.0006571705393096141	0.02127659574468085	0.8192464059779487	1	1
biomarkers/analysis	quinazolinones/adverse effects	0.0002818746185764276	0.0006571705393096141	0.02127659574468085	0.8192464059779487	1	1
biomarkers/analysis	lymphoma non-hodgkin/drug therapy	0.0002818746185764276	0.0006571705393096141	0.02127659574468085	0.8192464059779487	1	1
biomarkers/analysis	PIK3CD	0.0002818746185764276	0.0006571705393096141	0.02127659574468085	0.8192464059779487	1	1
ht29 cells	colorectal neoplasms/drug therapy	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
ht29 cells	b7-h1 antigen/genetics	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
abdominal pain/chemically induced	gastritis/complications	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
abdominal pain/chemically induced	enterocolitis/chemically induced	2.649280794742026e-11	3.1421702449265886e-10	0.02127659574468085	0.8192464059779487	1	1
gastrointestinal neoplasms/drug therapy	BTLA	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
gastrointestinal neoplasms/drug therapy	CD28	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
gastrointestinal neoplasms/drug therapy	CSF2	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
gastrointestinal neoplasms/drug therapy	HAVCR2	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
gastrointestinal neoplasms/drug therapy	IL15	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
gastrointestinal neoplasms/drug therapy	IL17C	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
gastrointestinal neoplasms/drug therapy	IL21	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
gastrointestinal neoplasms/drug therapy	IL22	0.0004354659220840995	0.0009805192947588996	0.02127659574468085	0.8192464059779487	1	1
gastrointestinal neoplasms/drug therapy	IL4	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
gastrointestinal neoplasms/drug therapy	LIF	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
colorectal neoplasms/drug therapy	b7-h1 antigen/genetics	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
antineoplastic agents/adverse effects	intestinal mucosa/chemistry	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
antineoplastic agents/adverse effects	leukemia lymphocytic chronic b-cell/drug therapy	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
antineoplastic agents/adverse effects	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
antineoplastic agents/adverse effects	purines/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
antineoplastic agents/adverse effects	colon/chemistry	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
antineoplastic agents/adverse effects	lymphocytosis/chemically induced	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
antineoplastic agents/adverse effects	protein kinase inhibitors/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
antineoplastic agents/adverse effects	apoptosis/drug effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
antineoplastic agents/adverse effects	quinazolinones/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
antineoplastic agents/adverse effects	lymphoma non-hodgkin/drug therapy	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
antineoplastic agents/adverse effects	PIK3CD	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
intestinal mucosa/chemistry	leukemia lymphocytic chronic b-cell/drug therapy	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
intestinal mucosa/chemistry	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
intestinal mucosa/chemistry	purines/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
intestinal mucosa/chemistry	colon/chemistry	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
intestinal mucosa/chemistry	lymphocytosis/chemically induced	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
intestinal mucosa/chemistry	protein kinase inhibitors/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
intestinal mucosa/chemistry	apoptosis/drug effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
intestinal mucosa/chemistry	quinazolinones/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
intestinal mucosa/chemistry	lymphoma non-hodgkin/drug therapy	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
intestinal mucosa/chemistry	PIK3CD	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
ustekinumab/therapeutic use	colitis ulcerative/drug therapy	0.0	0.0	0.02127659574468085	0.8192464059779487	1	1
ustekinumab/therapeutic use	interleukin-23/antagonists & inhibitors	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
ustekinumab/therapeutic use	interleukin-12/antagonists & inhibitors	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
colitis ulcerative/drug therapy	crohn disease/drug therapy	0.0	0.0	0.02127659574468085	0.8192464059779487	1	1
colitis ulcerative/drug therapy	interleukin-12/antagonists & inhibitors	0.0	0.0	0.02127659574468085	0.8192464059779487	1	1
colitis ulcerative/drug therapy	interleukin-23/antagonists & inhibitors	0.0	0.0	0.02127659574468085	0.8192464059779487	1	1
leukemia lymphocytic chronic b-cell/drug therapy	class i phosphatidylinositol 3-kinases/antagonists & inhibitors	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
leukemia lymphocytic chronic b-cell/drug therapy	purines/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
leukemia lymphocytic chronic b-cell/drug therapy	colon/chemistry	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
leukemia lymphocytic chronic b-cell/drug therapy	lymphocytosis/chemically induced	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
leukemia lymphocytic chronic b-cell/drug therapy	protein kinase inhibitors/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
leukemia lymphocytic chronic b-cell/drug therapy	apoptosis/drug effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
leukemia lymphocytic chronic b-cell/drug therapy	quinazolinones/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
leukemia lymphocytic chronic b-cell/drug therapy	lymphoma non-hodgkin/drug therapy	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
leukemia lymphocytic chronic b-cell/drug therapy	PIK3CD	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	purines/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	colon/chemistry	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	lymphocytosis/chemically induced	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	protein kinase inhibitors/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	apoptosis/drug effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	quinazolinones/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	lymphoma non-hodgkin/drug therapy	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	PIK3CD	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
purines/adverse effects	colon/chemistry	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
purines/adverse effects	lymphocytosis/chemically induced	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
purines/adverse effects	protein kinase inhibitors/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
purines/adverse effects	apoptosis/drug effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
purines/adverse effects	quinazolinones/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
purines/adverse effects	lymphoma non-hodgkin/drug therapy	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
purines/adverse effects	PIK3CD	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
colon/chemistry	lymphocytosis/chemically induced	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
colon/chemistry	protein kinase inhibitors/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
colon/chemistry	apoptosis/drug effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
colon/chemistry	quinazolinones/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
colon/chemistry	lymphoma non-hodgkin/drug therapy	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
colon/chemistry	PIK3CD	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
lymphocytosis/chemically induced	protein kinase inhibitors/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
lymphocytosis/chemically induced	apoptosis/drug effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
lymphocytosis/chemically induced	quinazolinones/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
lymphocytosis/chemically induced	lymphoma non-hodgkin/drug therapy	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
lymphocytosis/chemically induced	PIK3CD	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
protein kinase inhibitors/adverse effects	apoptosis/drug effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
protein kinase inhibitors/adverse effects	quinazolinones/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
protein kinase inhibitors/adverse effects	lymphoma non-hodgkin/drug therapy	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
protein kinase inhibitors/adverse effects	PIK3CD	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
apoptosis/drug effects	quinazolinones/adverse effects	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
apoptosis/drug effects	lymphoma non-hodgkin/drug therapy	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
apoptosis/drug effects	PIK3CD	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
quinazolinones/adverse effects	lymphoma non-hodgkin/drug therapy	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
quinazolinones/adverse effects	PIK3CD	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
lymphoma non-hodgkin/drug therapy	PIK3CD	1.8160047809523405e-05	6.398358813718091e-05	0.010638297872340427	0.8192464059779487	1	1
BTLA	CD28	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
BTLA	CSF2	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
BTLA	HAVCR2	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
BTLA	IL15	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
BTLA	IL17C	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
BTLA	IL21	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
BTLA	IL22	0.0004354659220840995	0.0009805192947588996	0.02127659574468085	0.8192464059779487	1	1
BTLA	IL4	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
BTLA	LIF	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
CD28	CSF2	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
CD28	HAVCR2	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
CD28	IL15	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
CD28	IL17C	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
CD28	IL21	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
CD28	IL22	0.0004354659220840995	0.0009805192947588996	0.02127659574468085	0.8192464059779487	1	1
CD28	IL4	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
CD28	LIF	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
CSF2	HAVCR2	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
CSF2	IL15	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
CSF2	IL17C	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
CSF2	IL21	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
CSF2	IL22	0.0004354659220840995	0.0009805192947588996	0.02127659574468085	0.8192464059779487	1	1
CSF2	IL4	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
CSF2	LIF	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
HAVCR2	IL15	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
HAVCR2	IL17C	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
HAVCR2	IL21	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
HAVCR2	IL22	0.0004354659220840995	0.0009805192947588996	0.02127659574468085	0.8192464059779487	1	1
HAVCR2	IL4	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
HAVCR2	LIF	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
IL15	IL17C	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
IL15	IL21	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
IL15	IL22	0.0004354659220840995	0.0009805192947588996	0.02127659574468085	0.8192464059779487	1	1
IL15	IL4	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
IL15	LIF	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
IL17C	IL21	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
IL17C	IL22	0.0004354659220840995	0.0009805192947588996	0.02127659574468085	0.8192464059779487	1	1
IL17C	IL4	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
IL17C	LIF	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
IL21	IL22	0.0004354659220840995	0.0009805192947588996	0.02127659574468085	0.8192464059779487	1	1
IL21	IL4	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
IL21	LIF	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
IL22	tryptophan/pharmacology	4.025857425205004e-11	4.719970774378281e-10	0.02127659574468085	0.8192464059779487	1	1
IL22	AHR	4.025857425205004e-11	4.719970774378281e-10	0.02127659574468085	0.8192464059779487	1	1
IL22	IL4	0.0004354659220840995	0.0009805192947588996	0.02127659574468085	0.8192464059779487	1	1
IL22	LIF	0.0004354659220840995	0.0009805192947588996	0.02127659574468085	0.8192464059779487	1	1
IL4	LIF	5.6933462758923525e-05	0.00016451028899179036	0.010638297872340427	0.8192464059779487	1	1
colitis/therapy	immunologic factors	0.0	0.0	0.02127659574468085	0.8192464059779487	1	1
gastritis/complications	enterocolitis/chemically induced	2.649280794742026e-11	3.1421702449265886e-10	0.02127659574468085	0.8192464059779487	1	1
enterocolitis/chemically induced	colitis ulcerative/physiopathology	0.0	0.0	0.02127659574468085	0.8192464059779487	1	1
enterocolitis/chemically induced	crohn disease/physiopathology	0.0	0.0	0.02127659574468085	0.8192464059779487	1	1
interleukin-23/antagonists & inhibitors	interleukin-12/antagonists & inhibitors	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
virus diseases/etiology	escherichia coli infections/drug therapy	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
virus diseases/etiology	clostridium infections/chemically induced	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
virus diseases/etiology	anti-bacterial agents/adverse effects	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
escherichia coli infections/drug therapy	clostridium infections/chemically induced	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
escherichia coli infections/drug therapy	anti-bacterial agents/adverse effects	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
clostridium infections/chemically induced	anti-bacterial agents/adverse effects	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
skin neoplasms/complications	colitis collagenous/drug therapy	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
colitis ulcerative/physiopathology	crohn disease/physiopathology	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
myasthenia gravis/diagnosis	immunosuppressive agents/therapeutic use	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
myasthenia gravis/diagnosis	skin neoplasms/immunology	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
myasthenia gravis/diagnosis	melanoma/immunology	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
myasthenia gravis/diagnosis	immunocompromised host	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
myasthenia gravis/diagnosis	prednisone/therapeutic use	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
myasthenia gravis/diagnosis	antibodies monoclonal humanized/adverse effects	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
neoplasms/diagnosis	dose-response relationship drug	7.130047663395089e-10	5.985719026060075e-09	0.02127659574468085	0.8192464059779487	1	1
neoplasms/diagnosis	drugs investigational/administration & dosage	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
neoplasms/diagnosis	antibodies monoclonal humanized/administration & dosage	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
dose-response relationship drug	antibodies monoclonal humanized/administration & dosage	7.130047663395089e-10	5.985719026060075e-09	0.02127659574468085	0.8192464059779487	1	1
dose-response relationship drug	feces	1.1102230246251565e-16	2.6962559169468086e-15	0.02127659574468085	0.8192464059779487	1	1
dose-response relationship drug	drugs investigational/administration & dosage	7.130047663395089e-10	5.985719026060075e-09	0.02127659574468085	0.8192464059779487	1	1
dose-response relationship drug	steroids/therapeutic use	6.027911503281302e-11	7.026822552396489e-10	0.04232441088995653	0.8192464059779487	1	1
colitis/diagnosis	gastrointestinal tract/metabolism	2.55351295663786e-15	5.85299599049577e-14	0.02127659574468085	0.8192464059779487	1	1
colitis/diagnosis	b7-h1 antigen/metabolism	2.55351295663786e-15	5.85299599049577e-14	0.02127659574468085	0.8192464059779487	1	1
colitis/diagnosis	programmed cell death 1 receptor/metabolism	2.55351295663786e-15	5.85299599049577e-14	0.02127659574468085	0.8192464059779487	1	1
glycoproteins/metabolism	b7-h1 antigen/antagonists & inhibitors	2.652003061598407e-10	2.6985880197116785e-09	0.031914893617021274	0.8192464059779487	1	1
glycoproteins/metabolism	biomarkers/metabolism	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
glycoproteins/metabolism	adenocarcinoma of lung/drug therapy	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
immunosuppressive agents/therapeutic use	skin neoplasms/immunology	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
immunosuppressive agents/therapeutic use	melanoma/immunology	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
immunosuppressive agents/therapeutic use	immunocompromised host	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
immunosuppressive agents/therapeutic use	prednisone/therapeutic use	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
immunosuppressive agents/therapeutic use	antibodies monoclonal humanized/adverse effects	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
drugs investigational/administration & dosage	antibodies monoclonal humanized/administration & dosage	1.2656542480726785e-14	2.2648549702353193e-13	0.010638297872340427	0.8192464059779487	1	1
colitis/epidemiology	b7-h1 antigen/antagonists & inhibitors	2.652003061598407e-10	2.6985880197116785e-09	0.031914893617021274	0.8192464059779487	1	1
gentian violet	inflammation	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
b7-h1 antigen/antagonists & inhibitors	biomarkers/metabolism	2.652003061598407e-10	2.6985880197116785e-09	0.031914893617021274	0.8192464059779487	1	1
b7-h1 antigen/antagonists & inhibitors	adenocarcinoma of lung/drug therapy	2.652003061598407e-10	2.6985880197116785e-09	0.031914893617021274	0.8192464059779487	1	1
antibodies monoclonal humanized/therapeutic use	steroids/adverse effects	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
skin neoplasms/immunology	antibodies monoclonal humanized/adverse effects	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
skin neoplasms/immunology	melanoma/immunology	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
skin neoplasms/immunology	immunocompromised host	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
skin neoplasms/immunology	prednisone/therapeutic use	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
lymphocytes/drug effects	vitamin d/administration & dosage	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
lymphocytes/drug effects	neutrophils/drug effects	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
lymphocytes/drug effects	antibodies monoclonal/adverse effects	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
feces	steroids/therapeutic use	0.0	0.0	0.02127659574468085	0.8192464059779487	1	1
biomarkers/metabolism	adenocarcinoma of lung/drug therapy	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
vitamin d/administration & dosage	neutrophils/drug effects	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
vitamin d/administration & dosage	antibodies monoclonal/adverse effects	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
melanoma/immunology	antibodies monoclonal humanized/adverse effects	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
melanoma/immunology	immunocompromised host	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
melanoma/immunology	prednisone/therapeutic use	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
intestinal mucosa/immunology	colon/immunology	0.0	0.0	0.02127659574468085	0.8192464059779487	1	1
feces/chemistry	leukocyte l1 antigen complex/analysis	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
immunocompromised host	antibodies monoclonal humanized/adverse effects	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
immunocompromised host	prednisone/therapeutic use	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
colon/immunology	t-lymphocyte subsets/immunology	0.0	0.0	0.02127659574468085	0.8192464059779487	1	1
neutrophils/drug effects	antibodies monoclonal/adverse effects	3.148352689663625e-10	2.6985880197116785e-09	0.010638297872340427	0.8192464059779487	1	1
inflammatory bowel diseases/complications	colitis microscopic/chemically induced	0.0	0.0	0.04232441088995653	0.8192464059779487	1	1
steroids/therapeutic use	lung neoplasms	0.0	0.0	0.02127659574468085	0.8192464059779487	1	1
prednisone/therapeutic use	antibodies monoclonal humanized/adverse effects	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
tryptophan/pharmacology	AHR	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
gastrointestinal tract/metabolism	programmed cell death 1 receptor/metabolism	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
gastrointestinal tract/metabolism	b7-h1 antigen/metabolism	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
b7-h1 antigen/metabolism	programmed cell death 1 receptor/metabolism	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
neoplasm recurrence local/drug therapy	endometrial neoplasms/drug therapy	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
neoplasm recurrence local/drug therapy	antibodies monoclonal humanized	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
endometrial neoplasms/drug therapy	antibodies monoclonal humanized	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
diarrhea/therapy	neoplasms/therapy	0.0	0.0	0.010638297872340427	0.8192464059779487	1	1
